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Use of amphetamines is a global health problem associated with significant 
social and financial burdens. Worldwide, amphetamines are second only to marijuana 
and opiates, respectively, for most abused illicit drug and highest prevalence of 
addiction. Epidemiological data reveal that adolescent and female drug users are at 
higher risk to develop addiction and have worse treatment outcomes than adults or 
males. Drug-induced cognitive deficits and neuroadaptations, in combination with 
different patterns of drug-seeking, represent possible mechanisms by which heightened 
vulnerability to addiction may be conferred in adolescents and females. Using a rodent 
model, this hypothesis was tested with two specific aims: (1) by assessing the impact of 
exposure to amphetamines on cognitive flexibility and 5-HT2C receptor structure and 
function (Experiments 1, 3, 4) and (2) by examining age and sex differences in 
intravenous methamphetamine self-administration (Experiment 2). In Experiment 1, 
male and female Sprague-Dawley rats were treated with amphetamine (3 mg/kg i.p.) 
during adolescence or young adulthood and tested in a Pavlovian outcome devaluation 
task at the same age in adulthood. Subsequently, the impact of systemic 5-HT2C 
receptor antagonism on devaluation was tested in a separate group of amphetamine-
treated rats. In Experiment 2, male and female Sprague-Dawley rats were trained to 
self-administer methamphetamine at 3 doses (0.02, 0.05, 0.08 mg/kg/inf) during 
adolescence or adulthood and, subsequently, tested for motivation to work for four 
doses of methamphetamine using a progressive ratio schedule of reinforcement. Rats 
that acquired methamphetamine self-administration at the highest dose were used in 
Experiments 3 and 4. In Experiment 3, rats with a history of self-administration were 
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tested for cognitive flexibility in an operant strategy shifting task. Subsequently, in 
Experiment 4, immunohistochemical analysis of the brains examined colocalization of 5-
HT2C receptors with parvalbumin-immunoreactive interneurons in the orbitofrontal 
cortex. These studies revealed complex interactions of age and sex on drug-induced 
changes and heightened drug-seeking in adult rats. Taken together and in the context 
of broader literature, this work supports the assertion that pervasive, and sometimes 
subtle, drug-induced changes in cognition and neurobiology along with different patterns 
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CHAPTER 1: DISSERTATION OBJECTIVES 
Drug use is a global health burden with high social and economic costs that are 
primarily attributable to a small percentage of individuals that transition from recreational 
to problem use (SAMHSA, 2013; UNODC, 2015). Females and adolescent-onset users 
disproportionately account for users that experience poor outcomes of drug use 
(Hillhouse et al., 2007; Rawson et al., 2007; Dluzen and Liu, 2008; Chen et al., 2009), 
but the mechanisms for heightened vulnerability in these populations remain unknown. 
Cognitive dysfunction and drug-induced neuroadaptations have been the focus of 
recent attempts to understand heightened vulnerability to addiction because these 
changes are frequently observed in drug users (Selby and Azrin, 1998; Rogers and 
Robbins, 2001) and are associated with poorer treatment outcomes (McKellar et al., 
2006; Feil et al., 2010; Henry et al., 2010). Patterns of drug taking, which in human 
users differ by age and sex (Van Etten and Anthony, 2001; Teter et al., 2006), are also 
a candidate mechanism of heightened vulnerability. 
Recent evidence from work in rodents suggests that male rats exposed to 
psychostimulants during adolescence exhibit similar (Hankosky et al., 2013; 
Hammerslag et al., 2014) or more severe (Harvey et al., 2009; Counotte et al., 2011; 
Sherrill et al., 2013) drug-induced cognitive deficits compared to males exposed during 
adulthood (Gulley and Juraska, 2013). However, examination of drug-induced changes 
that are unique in males compared to females is rare (Reichel et al., 2012; Hammerslag 
et al., 2014). Age- and sex-dependent differences in drug-seeking most commonly 
reveal that adolescents and females engage in similar patterns (Shahbazi et al., 2008; 
Reichel et al., 2012) or heightened (Shahbazi et al., 2008; Anker et al., 2011; Reichel et 
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al., 2012; Cox et al., 2013; Wong et al., 2013; Zlebnik et al., 2014; Wong and Marinelli, 
2015) drug-seeking relative to adults and males (Becker and Hu, 2008; Anker and 
Carroll, 2010). However, to my knowledge, only two studies examined the interaction of 
age and sex (Shahbazi et al., 2008; Anker et al., 2011), only one of which assessed 
AMPH self-administration (Shahbazi et al., 2008). There are currently no studies that 
have assessed age- and sex-differences in methamphetamine (METH) seeking.  
The search for possible mechanisms reveals that serotonin-2C receptors (5-
HT2CRs) are a likely candidate influencing drug-induced cognitive deficits (Homberg, 
2012) and drug seeking (Higgins and Fletcher, 2003). Despite recent advances, there 
remain significant gaps in our knowledge about sex- and age-specific differences in 
drug seeking and the effects of drug exposure on neurobiology and cognition. The 
research proposed here will use a rat model to identify age- and sex-specific differences 
in drug-induced cognitive deficits, METH seeking, and the contribution of 5-HT2CR 
dysregulation to drug-induced deficits in cognitive flexibility. The objective is two-fold: (1) 
to identify drug-induced cognitive deficits and neuroadaptations that may be unique in 
more vulnerable populations (adolescents and females) and (2) determine if differences 
in drug-seeking in these vulnerable populations could confer heightened vulnerability. 
My central hypothesis was that females and adolescents, compared to males and 
adults, would display characteristics that would likely contribute to increased 






I tested my central hypothesis by pursuing the following specific aims: 
1. Assess age- and sex-specific cognitive and neurobiological outcomes of drug 
exposure  
My working hypotheses were that females and adolescents would display 
heightened drug-induced deficits in cognitive flexibility that (1) would be ameliorated by 
treatment with a 5-HT2CR antagonist and (2) would be associated with increased co-
expression of 5-HT2CRs with parvalbumin-immunoreactive (PV-ir) interneurons in the 
orbitofrontal cortex (OFC). I tested my first hypothesis by examining age- and sex-
specific effects of experimenter-administered AMPH on reward devaluation and the 
modulation of this by 5-HT2CR antagonism (Experiment 1). I tested my second 
hypothesis by examining strategy shifting (Experiment 3) and colocalization of 5-HT2CRs 
with PV-ir interneurons in the OFC (Experiment 4) following intravenous METH self-
administration (rats from Aim 2, Experiment 2).  
2. Assess age- and sex-specific differences in METH self-administration  
My working hypothesis was that adolescent-onset and female rats would acquire 
METH self-administration more readily and work harder for METH than adult-onset and 
male rats. I tested this hypothesis in Experiment 2 by assessing age of onset- and sex-
dependent differences in acquisition of three doses of METH and motivation for four 




CHAPTER 2: BACKGROUND AND SIGNIFICANCE 
Drug Use Patterns 
Addiction is a chronically relapsing disorder, characterized by compulsive drug 
seeking to the exclusion of other activities. The United Nations Office on Drugs and 
Crime reports that up to 5% of the global population, 246 million people, used illicit 
drugs in 2013 (UNODC, 2015). Of those who used illicit drugs, nearly 12.2 million were 
injecting drug users who are at increased risk for a wide range of health problems, 
including HIV and hepatitis, and premature death (UNODC, 2015). In 2013, there were 
an estimated 187,100 drug-related deaths globally and the United States accounted for 
about 20% of the reported deaths (UNODC, 2015). In the United States alone, addiction 
has been estimated to cost $700 billion annually in lost productivity, health care, and 
crime (National Institute on Drug Abuse, 2015), $193 billion of which is attributed to the 
use of illicit drugs. Addiction is a pernicious global burden and, in fact, is the leading 
cause of preventable death, injury, and disability in the United States (National Institute 
on Drug Abuse, 2015).  
AMPHs, in particular, represent a global health problem. Worldwide, AMPHs are 
second only to marijuana and opiates, respectively, for most abused illicit drug (Rawson 
et al., 2002; Degenhardt and Hall, 2012) and highest prevalence of addiction 
(Degenhardt et al., 2013). Problem use of AMPHs is associated with psychological 
disturbances, infections (HIV or hepatitis C) among injecting users, violence, criminal 
activities, and higher risk of suicide (Sommers et al., 2006; Darke et al., 2008; Marshall 
and Werb, 2010; Degenhardt and Hall, 2012). In the United States, use of AMPHs 
poses a substantial social and financial burden. For example, METH is ranked as the 
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number one drug problem by many state law enforcement agencies (Kyle and Hansell, 
2005) and recent estimates suggest an economic toll of $23.4 billion per year (Nicosia 
et al., 2009).  
Use of AMPHs is especially problematic in females and adolescents, who 
represent populations of individuals that are known to have heightened vulnerability for 
addiction (Grant and Dawson, 1997; Clark et al., 1998; Becker and Hu, 2008; Kuhn et 
al., 2010; Merikangas and McClair, 2012). The growing number of prescribed AMPHs 
(e.g. Adderall) has increased their availability (DeSantis and Hane, 2010), particularly 
for college students (Lakhan and Kirchgessner, 2012). In fact, a study conducted 
between 2005 and 2006 revealed that over one-third of college students interviewed 
reported nonmedical use of prescription stimulants (DeSantis et al., 2010). Recent 
reports show that adolescent users represent more than 20% of those seeking 
treatment for METH addiction (Rawson et al., 2007) and that younger age of onset is 
associated with poorer treatment outcomes (Gonzales et al., 2008; Chen et al., 2009). 
More frequent use is associated with more social and psychological problems, and 
females report more problems than males (Sommers et al., 2006). In addition, females 
initiate METH use at younger ages and transition to disordered use more rapidly than 
males (Dluzen and Liu, 2008). In contrast to the reductions in alcohol and tobacco use 
among adolescents reported in recent years, use of AMPHs has remained constant. In 
2013, there were 144,000 new users of METH whose average age at initiation was 
about 19 years old (SAMHSA, 2013). Due to the extensive development of brain and 




Adolescence: A Period of Heightened Vulnerability 
Adolescence is the transitional period between childhood and adulthood (Spear, 
2000), which in humans is estimated to range from 12 up to 25 years (Dahl, 2004). 
There are normal, yet substantial behavioral, neurobiological, and cognitive changes 
occurring during this period (Spear, 2000; Sisk and Foster, 2004; Somerville et al., 
2010). Many of the behavioral manifestations appear to be evolutionarily conserved to 
promote the attainment of independence and transmission of one’s genes (Spear, 2012, 
2013; Luciana, 2013). However, the emergence of these behaviors may enhance 
vulnerability to addiction. Human adolescents exhibit heightened risk-taking (Arnett, 
1999; Trimpop et al., 1999; Steinberg, 2004; Cauffman et al., 2010), impulsivity 
(Steinberg et al., 2009; Harden and Tucker-Drob, 2011), novelty-seeking (Harden and 
Tucker-Drob, 2011), and peer-directed interactions (Hartup and Stevens, 1995), all of 
which have been implicated as contributors to the cycle of addiction (Martin et al., 2002; 
Brecht et al., 2004; Rawson et al., 2005; Fergusson et al., 2008; Tziortzis et al., 2011).  
Similar effects have been observed in rodents during their adolescent period, which has 
been estimated to range from postnatal days (Ps) 28–60 based on social, cognitive, 
hormonal, and neurophysiological changes that parallel markers of human adolescence 
(Tirelli et al., 2003; Spear, 2010). Specifically, adolescent rats and mice display 
increases in risk-taking (Laviola et al., 2003; Zoratto et al., 2013), impulsivity (Laviola et 
al., 2003; Burton and Fletcher, 2012; Doremus-Fitzwater et al., 2012), novelty-seeking 
(Adriani et al., 1998), and peer-directed behavior (Primus and Kellogg, 1989; Douglas et 
al., 2004). Consistent with epidemiological findings, in adolescent rodents the presence 
of peers increases drug intake (Logue et al., 2014) and those adolescents who are 
7 
 
riskier (Mitchell et al., 2014) or have increased responsiveness to novelty (Schramm-
Sapyta et al., 2011) have been found to self-administer more cocaine. As such, in both 
humans and rodents, adolescent-typical behaviors engender more drug seeking and 
taking. Indeed, adolescent rats self-administer  psychostimulants as much (Shahbazi et 
al., 2008; Anker et al., 2012) or more readily (Anker and Carroll, 2010; Anker et al., 
2011, 2012; Wong et al., 2013) than adults. Although evolutionarily conserved for 
reproductive success, some aspects of the adolescent behavioral repertoire may 
heighten vulnerability to drug use and, subsequently, addiction.  
Several groups suggest that differential development of brain regions associated 
with executive function and reward processing is responsible for adolescent-typical 
behaviors that contribute to heightened addiction vulnerability (Chambers et al., 2003; 
Galvan et al., 2006; Fareri et al., 2008; Ernst et al., 2009; Casey and Jones, 2010; 
Willoughby et al., 2013). Studies in humans and laboratory animals demonstrate that 
corticolimbic circuitry is among the last to develop. For example, longitudinal MRI 
studies have demonstrated that gray matter in the prefrontal cortex (PFC) follows an 
inverted U-shaped curve that peaks during early to mid-adolescence and declines to 
stable levels by the early twenties (Giedd et al., 1999; Sowell et al., 1999). Moreover, 
the timing of developmental gray matter loss differs by regions and occurs in a caudal to 
rostral fashion, such that the visual cortex undergoes developmental changes earlier 
than the frontal cortex (Gogtay et al., 2004). Post-mortem findings have shown that 
synapse elimination continues to occur in the PFC during adolescence (Huttenlocher 
and Dabholkar, 1997; Glantz et al., 2007) and into the early thirties (Petanjek et al., 
2011). Furthermore, recent gene expression of 5-HT receptors in the PFC has revealed 
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a peak in expression of 5-HT2A and 5-HT2CRs during adolescence that then decreases 
to adult levels (Lambe et al., 2011). Complementary changes have been observed in 
rodents during the adolescent period. Between P35 and P90, male and female rats lose 
neurons in the medial PFC (mPFC) in a region- and layer-specific manner (Markham et 
al., 2007), while frontal white matter increases. During this time in the PFC, spine 
density peaks (Koss et al., 2014), NMDA receptor expression peaks (Insel et al., 1990) 
and synaptic proteins, particularly vesicle proteins, undergo dynamic changes (Counotte 
et al., 2010). Considerable changes to monoamine neurotransmitter systems have been 
reported during adolescence. For example, dopaminergic innervation of the PFC 
increases across development until stable levels are reached by P60 (Kalsbeek et al., 
1988). Furthermore, in both the striatum and frontal cortex, there is a significant 
overproduction and subsequent elimination of dopamine D1 and D2 receptors (Andersen 
et al., 2000) and neurotransmitter-specific fluctuations in the density of monoamine 
transporters (Moll et al., 2000; Bradshaw et al., 2016). In addition to changes within 
corticolimbic regions, there are changes between the connectivity of corticolimbic 
regions. For example, during adolescence there is a significant increase in connectivity 
between the basolateral amygdala and mPFC (Cunningham et al., 2002, 2008) and 
higher expression of D1 receptors on afferent projections from the mPFC to the nucleus 
accumbens (Brenhouse et al., 2008).  
Consistent with the structural changes occurring in corticolimbic regions during 
adolescence, there are also functional changes accompanied by cognitive gains  
(Casey et al., 2000; Adleman et al., 2002; Luna et al., 2004; Durston et al., 2006; 
Huizinga et al., 2006; Yurgelun-Todd, 2007). Generally, regions of reward processing 
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and executive control are more and less active, respectively, during task demands in 
adolescents compared to adults (Galvan et al., 2006; Eshel et al., 2007). During tests of 
reward appraisal or emotion regulation, adolescents show greater nucleus accumbens 
(Galvan et al., 2006) and amygdala activation (Hare et al., 2008), but attenuated OFC 
activation compared to adults (Galvan et al., 2006). In assessments of risk-taking, 
adolescents show less activation of prefrontal areas, which correlates with making 
riskier decisions (Eshel et al., 2007). In rodents, development of cognitive functions 
between adolescence and adulthood is also accompanied by functional changes. For 
example, activation of D2 receptors (Benoit-Marand and O’Donnell, 2008) and co-
activation of D1 and NMDA receptors (Huppé-Gourgues and O’Donnell, 2012) produce 
opposite effects on excitability in the nucleus accumbens in adolescents and adults. 
Furthermore, in the PFC, D2 receptor-mediated inhibition does not develop until after 
adolescence (Tseng and O’Donnell, 2007a, 2007b). Lastly, in the OFC (Sturman and 
Moghaddam, 2011) and dorsal striatum (Sturman and Moghaddam, 2012) reward and 
reward-related events increase activity in adolescents, but decrease activity in adults. 
As such, several lines of evidence demonstrate that there are functional consequences 
of the extensive brain changes occurring during adolescence. This reorganization of 
structure and function may reflect a sensitive period during which vulnerability to drugs 
of abuse is heightened. In female users, who represent a second population of at-risk 
users, sexually dimorphic behavioral and neurobiological development may increase 





Sex Differences in Addiction Vulnerability 
In addition to age, sex differences play a critical role in the transition to addiction. 
Although male drug users outnumber female drug users, females initiate use as readily 
(Van Etten and Anthony, 2001), develop addiction more rapidly (Anthony et al., 2005), 
and have more severe symptoms than males (Randall et al., 1999; Sommers et al., 
2006; Kuhn et al., 2010). This epidemiological evidence is supported by some studies in 
rodents examining behavioral characteristics and patterns of drug seeking. Studies 
report that female rats display heightened impulsivity (Anker et al., 2008; Burton and 
Fletcher, 2012) and poorer decision-making than males (van den Bos et al., 2012). 
However, our lab (Hammerslag et al., 2014) and others (Jentsch and Taylor, 2003; 
Bayless et al., 2012) have found better impulse control in females than males and a 
recent study reported no sex differences in decision making (Peak et al., 2015). 
Regardless of the direction of the effect, these studies reveal that male and female rats 
often perform divergently on tasks assessing PFC-sensitive functions. These behavioral 
dimorphisms may contribute to sex differences in psychostimulant self-administration. 
Specifically, under certain conditions, females self-administer more drug (Davis et al., 
2008; Reichel et al., 2012; Westenbroek et al., 2013), escalate intake faster (Reichel et 
al., 2012), work harder to obtain drug (Roth and Carroll, 2004; Westenbroek et al., 
2013), and exhibit greater drug-primed reinstatement than males (Holtz et al., 2012). In 
other reports, however, males acquire AMPH and cocaine self-administration faster 
than females (Lynch and Carroll, 1999; Shahbazi et al., 2008) and take similar amounts 
of METH as females (Holtz et al., 2012). The differences that exist in behavior and drug 
seeking could be accounted for by neurobiological sexual dimorphisms.   
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Males and females display differential development and function of corticolimbic 
regions (Cosgrove et al., 2007), which likely contribute to sex-dependent behavioral 
manifestations. Studies in humans show that males have greater cortical volume and 
surface area than females (Wierenga et al., 2014) and are known to have relatively 
more white, but less gray matter than women (Gur et al., 1999). Furthermore, the 
developmental peak in gray matter occurs earlier in females than in males (Giedd et al., 
1999). There are also regional differences in receptor expression between males and 
females. Studies show that men have greater expression of 5-HT2/2A (Biver et al., 1996; 
Soloff et al., 2010) and 5-HT1A (Moses-Kolko et al., 2011) receptors in the frontal cortex 
and greater expression of 5-HT4 receptors in limbic regions, with the greatest difference 
observed in the amygdala (Madsen et al., 2011). Assessment of D2 receptors revealed 
the opposite, that females had higher expression in the frontal cortex compared to 
males. However, a recent study failed to observe sex differences in 5-HT2A/C and the 5-
HT transporter gene expression in several regions, including the hippocampus and 
striatum (Sugden et al., 2009) and there is no consensus on sex differences in 
monoamine transporter expression (Mozley et al., 2001; Staley et al., 2001; Burke et al., 
2011). Consistent with studies in humans, there is a development increase in white 
matter from adolescence to adulthood that results in male rats having significantly 
greater volume of white matter than female rats by adulthood (Markham et al., 2007; 
Willing and Juraska, 2015). Sexual dimorphisms are also observed in corticolimbic 
regions. For example, female rats have greater dendritic arborization in the OFC, but 
less in the mPFC (Kolb et al., 2004). During adolescence, females lose more neurons 
(Markham et al., 2007; Willing and Juraska, 2015) and undergo more synaptic pruning 
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(Drzewiecki et al., 2016) in the mPFC than males. Recently, the Juraska lab 
demonstrated that the loss of neurons in females and loss of synapses in both sexes 
occurs around the time of puberty and is associated with gains in cognitive performance 
(Juraska and Willing, 2016). In the amygdala, males have greater volume and neuron 
number than females (Równiak, 2013), but changes in dendritic complexity across 
development are similar in males and females (Koss et al., 2014). Furthermore, gene 
and protein expression of 5-HT1A/2A receptors exhibit sexually dimorphic patterns in 
limbic regions (Zhang et al., 1999) and female rats fail to exhibit the transient 
developmental increase in D1 and D2 receptor expression in the striatum and nucleus 
accumbens observed in males (Andersen et al., 1997, 2002b).  
Studies of PFC functional connectivity reveal that females exhibit more 
coordinated, versus independent, activity than males (Zuo et al., 2010). During tasks 
that involve the PFC, females show greater activation of the OFC during risky decision-
making than males (Lee et al., 2009) and greater left-biased lateralization in the PFC 
during a working memory (Speck et al., 2000) and risk-taking task (Bolla et al., 2004). 
Studies of functional dissociations using rodents are sparse, but consistent with sex-
dependent differences observed in humans. In adults, 5-HT1A-mediated inhibition in the 
PFC is significantly reduced in males compared to females (Goodfellow et al., 2009), 
and in adolescent mice, females exhibit attenuated GABAB-mediated inhibition in the 
mPFC compared to males (de Velasco et al., 2015). However, a recent study found no 
sex differences in physiological properties of medium spiny neurons in the nucleus 
accumbens (Willett et al., 2016). Clearly, sex differences in brain structure and function 
exist for a range of outcomes, and these differences may contribute to disparate 
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outcomes of drug use. One possible mechanism would be by differentially modulating or 
augmenting drug-induced cognitive dysfunction. 
Drug-induced Cognitive Dysfunction 
Drug abusers display significant deficits in cognitive functioning (Selby and Azrin, 
1998; Rogers and Robbins, 2001) and even perform similar to individuals with prefrontal 
lesions (Rogers et al., 1999). Cognitive deficits are thought to contribute to the cycle of 
addiction by increasing drug seeking (e.g. poor impulse control) and/or reducing users’ 
capacity to engage in treatment programs (e.g. poor planning, attention, and cognitive 
flexibility; Rogers and Robbins, 2001). Indeed, studies demonstrate that cognitive 
deficits result in poorer treatment outcomes (Feil et al., 2010), and increase the 
likelihood of dropping out of treatment (Moeller et al., 2001; McKellar et al., 2006; 
Verdejo-García et al., 2012). Furthermore, drug-induced cognitive deficits are 
associated with less understanding of activities required in daily life, such as finance 
and transportation management (Henry et al., 2010; Ellis et al., 2016), which likely 
complicates users’ attempts to reenter society. 
In psychostimulant abusers, deficits have been observed in PFC-sensitive tasks 
assessing attention (McKetin and Mattick, 1998; Ornstein et al., 2000; Hosak et al., 
2012), behavioral inhibition (Monterosso et al., 2005; Salo et al., 2009), and decision-
making (Rogers et al., 1999; van der Plas et al., 2009). However, there have also been 
reports of preserved cognitive functioning on certain tasks (Ornstein et al., 2000; 
Johanson et al., 2006; van der Plas et al., 2009; Roberts et al., 2013) and some argue 
that the drug-induced deficits fall within the normal range of functioning (Hart et al., 
2012). In rodents exposed to AMPHs during adulthood, there is evidence for 
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impairments in extradimensional shifts and reversal learning in an attentional set shifting 
task (Featherstone et al., 2008; Izquierdo et al., 2010; Parsegian et al., 2011; Cox et al., 
2016), impaired visual attention on a five-choice serial reaction time task (Fletcher et al., 
2007b), and impaired impulse control in a differential reinforcement of low rates of 
responding task (Peterson et al., 2003). However, consistent with the human literature, 
some studies observed no drug-induced deficits in executive function (Stefani and 
Moghaddam, 2002; Featherstone et al., 2008). Recent studies, which have focused on 
the potential for age-dependent differences in the effects of repeated drug exposure on 
cognition, have demonstrated that adolescents exhibit similar or heightened drug-
induced deficits in performance. Recent studies demonstrate that adolescent 
psychostimulant exposure results in more severe deficits in working memory (Sherrill et 
al., 2013), attention (Counotte et al., 2011), impulse control (Counotte et al., 2011), and 
cognitive flexibility (Harvey et al., 2009) than adult exposure and that females are more 
impaired on a variety of tasks than males following METH exposure (Acevedo et al., 
2007). Other studies reveal that females and rats exposed to AMPHs during 
adolescence exhibit similar drug-induced cognitive deficits (Reichel et al., 2012; 
Hankosky et al., 2013; Hammerslag et al., 2014). 
These deficits in cognitive functioning are associated with structural and 
functional brain changes. More than two decades ago, Nora Volkow and colleagues 
(1992) demonstrated that cocaine abusers have reduced metabolic activity in the OFC 
that persists 4-6 months after abstinence. Since then studies have shown that 
psychostimulant abusers have less prefrontal gray matter (Fein et al., 2002; Franklin et 
al., 2002; Matochik et al., 2003), recruit the PFC less during tasks of behavioral 
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inhibition (Kaufman et al., 2003; Hester and Garavan, 2004) and have fewer dopamine 
transporter binding sites in the striatum (McCann et al., 1998, 2008; Sekine et al., 2001; 
Johanson et al., 2006), PFC (Sekine et al., 2003), and amygdala (Sekine et al., 2003) 
than non-drug users. Studies in rodents are consistent with the clinical literature and 
demonstrate a wide variety of structural and functional brain changes following 
psychostimulant exposure. Escalating doses of AMPH over five weeks increase 
dendritic length and density in the PFC and nucleus accumbens (Robinson and Kolb, 
1997) but decrease spine density in the OFC (Crombag et al., 2005). Repeated METH 
exposure decreases spine density in the dorsomedial striatum (Jedynak et al., 2007) 
and anterior cingulate (Coutinho et al., 2008), but increases spine density in the 
dorsolateral striatum (Jedynak et al., 2007). Repeated exposure to METH or AMPH 
increases basal and burst firing rate of mPFC pyramidal neurons (Parsegian et al., 
2011), decreases evoked responses of medium spiny neurons in the nucleus 
accumbens (Graves et al., 2015), reduces PV immunoreactivity in layer V of the 
prelimbic mPFC (Morshedi and Meredith, 2007) and changes gene expression of AMPA 
and NMDA receptor subunits in the mPFC and nucleus accumbens (Lu and Wolf, 1999; 
Lu et al., 1999). Recent work has begun to investigate the effects of AMPH exposure 
during adolescence. At low doses, adolescent AMPH exposure increases firing rate of 
5-HTergic and dopaminergic neurons and at a higher dose increases firing rate of 
noradrenergic neurons (Labonte et al., 2012). Another group recently demonstrated that 
AMPH exposure in young (P22-31), but not old (P75-84) mice increases tyrosine 
hydroxylase fibers in the mPFC, while decreasing varicosities (Reynolds et al., 2015). 
Lastly, our lab recently demonstrated that AMPH exposure during adolescence or 
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adulthood reduces dopamine-mediated inhibition of mPFC pyramidal neurons, in part 
via reduced sensitivity of D1 receptors (Kang et al., 2016). Very little exists for sex 
differences following chronic psychostimulant exposure, but studies assessing the acute 
effects reveal differential impact of psychostimulants in males and females (Staiti et al., 
2011; Weiss et al., 2015). Converging evidence demonstrates that psychostimulant 
exposure produces structural and functional changes in corticolimbic regions and the 
search for a potential therapeutic target indicates that serotonin’s vast actions may be 
one of many suitable candidates.     
Serotonergic Mechanisms of Addiction  
Serotonin is a monoamine neurotransmitter with 14 identified subtypes divided 
into seven classes that are localized primarily to the central nervous system (Hoyer et 
al., 1994; Barnes and Sharp, 1999). All of the 5-HT receptors are G-protein coupled, 
with the exception of the 5-HT3 receptor which is a ligand-gated ion channel (Hoyer et 
al., 2002). Serotonin is characterized by remarkable functional heterogeneity (Raymond 
et al., 2001) owing to the diverse family of receptor subtypes and modulation of signal 
transduction by receptor RNA-editing (Burns et al., 1997; Hoyer et al., 2002; Gardiner 
and Du, 2006; Hannon and Hoyer, 2008). Many 5-HT receptors, notably 5-HT1 and 5-
HT2 subtypes, are found extensively in corticolimbic regions, including the frontal cortex, 
hippocampus, amygdala, and nucleus accumbens, suggesting they may be involved in 
executive functions and the regulation of emotion (Hoyer et al., 1994; Pompeiano et al., 
1994; Barnes and Sharp, 1999; Clemett et al., 2000; Liu et al., 2007). Indeed many 
studies demonstrate an involvement of 5-HT in neuropsychiatric disorders (Heisler et 
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al., 1998; Parks et al., 1998; Lerer et al., 2001), including addiction (Higgins and 
Fletcher, 2003; Hayes and Greenshaw, 2011; Kirby et al., 2011).    
Serotonin has gained recent attention for its likely role in addiction (Kirby et al., 
2011) due to its involvement in drug-induced cognitive deficits (Homberg, 2012). Drug 
abusers display characteristic deficits in PFC-mediated tasks (Rogers and Robbins, 
2001) that contribute to the cycle of addiction (McKellar et al., 2006; Feil et al., 2010). 
For example, impulsivity is known to result in poorer outcomes of addiction and reduced 
treatment compliance (Evenden, 1999; Jentsch and Taylor, 1999; Crews and Boettiger, 
2009) and is modulated in part by 5-HT (Kirby et al., 2011). Studies suggest that tight 
regulation of 5-HT levels is required for optimal impulse control as both depletion 
(Harrison et al., 1997; Crean et al., 2002) and elevated levels of 5-HT (Dalley et al., 
2002) are associated with heightened impulsivity. In addition, 5-HT depletion impairs 
reversal learning (Clarke et al., 2005, 2007), a task known to assess cognitive flexibility. 
Serotonin is also linked with the regulation of drug seeking. Studies demonstrate a role 
for 5-HT transmission in the reinforcing effects of psychostimulants (Rocha et al., 1998; 
Sora et al., 2001; Higgins and Fletcher, 2003; Rothman and Baumann, 2009; Filip et al., 
2010; Pelloux et al., 2012), perhaps due to 5-HT’s role in mediating dopamine release in 
the nucleus accumbens (Alex and Pehek, 2007; Leggio et al., 2009). Many of 5-HT’s 
effects on cognition and drug-seeking are mediated in part by actions at 5-HT2CRs.   
Serotonin-2C receptors are coupled to the phospholipase C signaling pathway 
and are broadly expressed throughout the brain including in the choroid plexus, 
hippocampus, cortex, striatum, and substantia nigra (Abramowski et al., 1995; 
Pasqualetti et al., 1999; López-Giménez et al., 2001). Originally designated 5-HT1C 
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receptors, they were first identified just over 30 years ago in the choroid plexus of the 
pig and rat (Pazos et al., 1985; Yagaloff and Hartig, 1985). These receptors have 
diverse functional properties (Tohda et al., 2006), such as considerable levels of 
constitutive activity (Berg et al., 2008) and multiple isoforms that result from RNA editing 
(Burns et al., 1997). RNA editing leads to a change in the level of constitutive activity 
(Herrick-davis et al., 1999; Niswender et al., 1999), as well as a reduction in agonist 
binding and potency (Wang et al., 2000). These receptors have been implicated in 
executive processes and many aspects of drug seeking (Higgins and Fletcher, 2003; 
Müller and Carey, 2006). For example, antagonism of 5-HT2CRs enhances reversal 
learning by decreasing perseverative responding (Boulougouris et al., 2008; 
Boulougouris and Robbins, 2010). In seeming contrast to its effects on cognitive 
flexibility, inhibition of 5-HT2cRs impairs impulse control (Fletcher et al., 2007a) while 
activation reduces acute AMPH-induced impulsivity (Fletcher et al., 2011). Mice with a 
genetic mutation that decreases the function of 5-HT2CRs (Burns et al., 1997) exhibit 
impaired attention on a 5-choice serial reaction time task (Doe et al., 2009; Relkovic et 
al., 2010). Furthermore, mice lacking 5-HT2CRs are impaired in tasks of reversal 
learning and attention (Pennanen et al., 2013). In studies assessing drug seeking, 
activation of 5-HT2CRs reduces responding for cocaine, breakpoints in PR schedules, 
and drug primed as well as stress- and cue-induced reinstatement (Grottick et al., 2000; 
Fletcher et al., 2008). Consistent with these observations, blockade of 5-HT2CRs 
increases drug-primed reinstatement (Fletcher et al., 2002). However, the role of 5-
HT2CRs appears to be nuanced as evidence demonstrates that administration of an 
inverse agonist decreases cue-induced reinstatement (Graves and Napier, 2012) and 5-
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HT2CR knock-out mice reach higher breakpoints in cocaine self-administration than wild-
types (Rocha et al., 2002). As such, several lines of evidence highlight a complex role 
for 5-HT2CRs in the regulation of cognitive processes and drug-seeking. 
In layers V and VI of the mPFC 5-HT2CRs are localized primarily to PV-ir neurons 
compared to calbindin-ir and calretinin-ir neurons (Fig. 2.1; Liu et al., 2007). Inhibitory 
neurons make up 10-30% of all cells in the cortex (Markram et al., 2004; Yuste, 2005) 
and, in the PFC, PV-ir interneurons are the most abundant, making up ~40% of all 
interneurons (Markram et al., 2004; Rudy et al., 2011). PV interneurons are fast-spiking 
cells that are morphologically characterized as either basket or chandelier cells 
(Kawaguchi and Kubota, 1993, 1998; Chow et al., 1999; Kepecs and Fishell, 2014). The 
chandelier subtype forms multiple axo-axonic connections on the initial axon segment of 
pyramidal cells with vertical rows of axon terminals, termed cartridges (Howard et al., 
2005). Basket cells, on the other hand, make multiple synaptic connections targeting 
proximal dendrites and somata of pyramidal cells (Kawaguchi and Kubota, 1993) and in 
layer V of the PFC, ~60% of PV-ir interneurons are basket cells (Kawaguchi and 
Kubota, 1993; Jiang et al., 2015). As a result of their unique axon terminal distribution 
on pyramidal cells, PV-ir interneurons command tight regulatory control of pyramidal 
cells in the PFC (Kubota and Kawaguchi, 1994). As such, in combination with their 
localization to PV-ir interneurons in the PFC, 5-HT2CRs are ideal candidates to 
investigate as one potential mechanism underlying drug-induced changes in cognition.   
Gaps in Current Knowledge 
Despite recent advances in our understanding of age- and sex-dependent 
vulnerabilities to addiction, there remain significant gaps in our knowledge about the 
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drug-seeking patterns and cognitive and neurobiological consequences of drug 
exposure in more vulnerable populations. My dissertation aims to address these gaps in 
knowledge by examining age- and sex-dependent drug-induced cognitive inflexibility 
and differential patterns of drug seeking in at-risk populations. Furthermore, these 
experiments will assess changes in function or expression of 5-HT2CRs, a potential 
therapeutic target of addiction pharmacotherapies, in the role of cognitive dysfunction. 
These experiments will significantly advance our understanding of the progression and 
consequences of drug-seeking and exposure in users that display heightened 
vulnerability to addiction. Furthermore, the knowledge gained from these studies could 
subsequently be used to help improve existing prevention and treatment strategies, as 
well as suggest avenues for individualized treatment approaches in adolescent and 
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Figure 2.1 Simplified circuit diagram of localization of 5-HT2CRs in the PFC. Circuit 
diagram showing a layer V pyramidal (PYR) neuron projecting to subcortical structures 
(e.g. basolateral amygdala). In the PFC, PV-ir interneurons have tight regulatory control 
over the output of these layer V pyramidal cells due multiple synaptic contacts (shown in 
red) proximal to the axon initial segment. In the PFC, 5-HT2CRs are primarily localized to 




CHAPTER 3: AGE- AND SEX-SPECIFIC EFFECTS OF AMPHETAMINE ON 
REWARD DEVALUATION: MODULATION BY SEROTONIN-2C RECEPTORS 
Rationale 
Drug-induced deficits in cognition are a putative mechanism underlying poor 
treatment outcomes for drug abusers (Rogers and Robbins, 2001; McKellar et al., 
2006). Recently, studies have begun to examine drug-induced deficits in cognition 
following adolescent drug exposure. Some studies report more significant drug-induced 
deficits in PFC-sensitive tasks following adolescent versus adult exposure (Harvey et 
al., 2009; Counotte et al., 2011; Sherrill et al., 2013), but others have failed to detect 
age-dependent deficits (Hankosky et al., 2013; Hammerslag et al., 2014; Kantak et al., 
2014). Recent behavioral deficits I have observed implicate dysregulation of the OFC 
following psychostimulant exposure. Specifically, rats treated with AMPH exhibited 
heightened perseveration (Hankosky & Gulley, 2012) and impaired reversal learning 
(Hankosky et al., 2013), two behaviors known to be sensitive to OFC disruption (Dias et 
al., 1996; Freedman et al., 1998; McAlonan and Brown, 2003; Clark et al., 2004; 
Bissonette et al., 2008; Chase et al., 2012). Moreover, several studies have 
demonstrated that both systemic (Clarke et al., 2007; Boulougouris et al., 2008; van der 
Plasse and Feenstra, 2008; Bari et al., 2010; Brigman et al., 2010; Brown et al., 2012) 
and intra-OFC manipulations of serotonin (Clarke et al., 2005, 2007; Boulougouris and 
Robbins, 2010) affect reversal learning and perseveration. Specifically, systemic and 
intra-OFC antagonism of 5-HT2C, but not 5-HT2A, receptors enhance reversal learning 
by reducing perseverative errors (Boulougouris et al., 2008; Boulougouris and Robbins, 
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2010). These data suggest that changes in 5-HT2CRs and the OFC are likely 
mechanisms for the behavioral changes I observed previously in AMPH-exposed rats.  
In order to test the hypothesis that 5-HT2CRs are involved in the OFC-sensitive 
deficits observed following AMPH exposure, this experiment will examine the effects of 
a 5-HT2CR antagonist on an OFC-sensitive reward devaluation task in male and female 
rats treated with AMPH during adolescence or young adulthood. Based on my previous 
findings (Hankosky and Gulley, 2012; Hankosky et al., 2013), I hypothesize that AMPH-
treated rats will exhibit impaired reward devaluation that will be ameliorated by 
pretreatment with the 5-HT2CR antagonist, SB 242084.  
Methods 
Experiment 1a 
Male (n = 20-22/group) and female (n= 20-22/group) Sprague-Dawley rats, which 
were offspring of rats bred in our colony, were assigned to one of three groups (see 
Table 3.1) – control, adolescent-exposed, and adult-exposed – such that litter was 
distributed equally across groups. Rats were pair-housed on a 12-h light/dark cycle 
(lights on at 0800) and experiments were done during the light cycle. Ten injections 
were given every other day during adolescence (P27-43) and adulthood (P85-103) as 
follows: those in the control group received saline at both ages, those in the adolescent-
exposed group received 3 mg/kg d-AMPH during adolescence and saline during 
adulthood, and those in the adult-exposed group received saline during adolescence 
and 3 mg/kg d-AMPH during adulthood. Following treatment, rats were left undisturbed 
in their home cages until P125 at which time they were food restricted to 85% of free-
feeding weight.  
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Starting on P130, rats began outcome devaluation procedures as described 
previously (Pickens et al., 2003). Briefly, rats were trained in 10 daily Pavlovian 
conditioning sessions (8 trials/session) wherein a conditioned stimulus (CS; 10-sec 
flashing lights at 3 Hz) coincided with delivery of two food pellets (unconditioned 
stimulus; US). Rats were then matched for conditioning and assigned to either a paired 
(devalued) or unpaired (non-devalued) group. On days 1 and 3 of reward devaluation, 
rats in the devalued group were moved to an individual cage where they received 10-
min access to 100 pellets and were then injected with 0.3 M LiCl. The non-devalued 
group was also moved to an individual cage for 10 mins and then received the LiCl 
injection without prior access to the pellets. On days 2 and 4, both groups were placed 
in their individual cages, but only the non-devalued group received 10-min access to 
100 food pellets, and no injections were given. Following devaluation of the reward via 
LiCl-induced aversion, rats underwent a test session wherein the CS was presented 8 
times, but no reward was delivered. The day following devaluation testing, rats were 
given 10-min access to food pellets to determine the extent of conditioned aversion to 
the pellets in the devalued and non-devalued groups. 
Experiment 1b 
A separate cohort of male (n = 23-24/group) and female (n = 19-27/group) rats, 
were assigned to either adolescent- or adult-exposed groups as described above. 
Pavlovian conditioning, reward devaluation, and devaluation testing were identical to 
procedures described in experiment 1a. The only difference was that 20 mins prior to 
devaluation testing, these rats were injected (i.p.) with 1.0 mg/kg SB 242084 or vehicle 
(8% cyclodextrine/saline solution with 25 mM citric acid). This dose was chosen based 
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on the ability of this 5-HT2CR antagonist to reduce trials and errors to criterion during a 
serial reversal learning task (Boulougouris et al., 2008).  
Data Analysis 
 Dependent measures included number of trough entries (conditioned responses; 
CRs) during the last 5-sec of stimulus presentation and during the 5 sec prior to onset of 
the CS. Analyzing responses during only the last 5-sec of CS presentation is typical 
(Gallagher et al., 1999; Pickens et al., 2003, 2005) because previous work 
demonstrated that most CRs to a visual cue occur during the last 5 sec of stimulus 
presentation (Holland, 1977). For Pavlovian conditioning and the devaluation test, an 
“Approach” score was calculated by subtracting trough entries during the last 5 sec of 
the CS from those made in the 5 sec preceding onset of the CS. Additionally, entries 
into the trough immediately following termination of the CS (Post-CS entries) were 
analyzed across the entire devaluation test and on the first trial only (Pickens et al., 
2005). The first trial allows assessment of devaluation in the absence of extinction 
effects and others have reported behavior from only the first half of devaluation testing 
(Pickens et al., 2003, 2005). Number of pellets consumed on each day of reward 
devaluation and during the aversion probe test was assessed. Pavlovian conditioning 
data were analyzed using a 3-way repeated measures ANOVA (treatment x sex x day). 
Reward devaluation was assessed using a 4-way repeated measures ANOVA 
(treatment x sex x value x day). Measures collected during the devaluation test were 
assessed using a 3-way ANOVA (sex x treatment x value). Devaluation test data 
following drug challenge were analyzed separately for males and females in 3-way 
repeated measures ANOVA (treatment x value x drug). Preplanned comparisons were 
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used to test the a priori hypothesis that during devaluation testing, measures from rats 
in the devalued (paired) condition would differ from those in the non-devalued 
(unpaired) condition (Singh et al., 2010).  
Results 
Experiment 1a 
Rats trained across 10 days in a Pavlovian conditioning paradigm readily 
acquired the association. Three-way repeated measures ANOVA of Approach revealed 
a significant main effect of day (F9,1089 = 54.8; p < 0.001) and a sex by treatment 
interaction (F2,121 = 3.8; p < 0.05). Investigation of these effects revealed that rats 
significantly increased Approach behavior across days as evidenced by significantly 
higher Approach on all other days compared to day 1. Post-hoc analysis of the sex by 
treatment interaction demonstrated that adolescent-exposed females had significantly 
higher Approach than adult-exposed females and adolescent-exposed males (Fig. 3.1 
A-B).   
Following 10-days of Pavlovian conditioning, the food pellet reward was devalued 
in half of the rats by pairing it with LiCl. Four-way repeated measures ANOVA revealed 
significant main effects of value (F1,115 = 1130.4; p < 0.001) and day (F2,224 = 415.0; p < 
0.001) as well as significant sex by value (F1,115 = 4.8; p < 0.05), value by day (F2,224 = 
473.8; p < 0.001), and sex by treatment by day (F4,224 = 2.6; p < 0.05) interactions. As 
expected, there were no differences between devalued and non-devalued groups on 
day 1, but on day 2 and during the aversion probe, rats in the devalued condition 
consumed significantly fewer pellets than rats in the non-devalued condition (Fig. 3.1 C-
D). Investigation of the sex by value interaction showed that when the reward was 
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devalued, males consumed significantly fewer pellets than females. Investigation of the 
3-way interaction revealed that on day 2 of reward devaluation, adolescent-exposed 
females consumed significantly fewer pellets than female controls, adult-exposed 
females, and adolescent-exposed males. However, in rats exposed to AMPH during 
adulthood, reward devaluation had a greater impact in males than females as 
evidenced by significantly reduced consumption of pellets on day 2 in males.  
When Approach and Post-CS entries were analyzed across the entire 
devaluation test, there was no evidence of outcome devaluation in the control groups 
(data not shown). Three-way repeated measures ANOVA of Approach and Post-CS 
entries revealed no significant main effects or interactions. However, when Approach 
was analyzed for the first trial only, 3-way repeated measures ANOVA revealed a 
significant treatment by sex by value interaction (F2,115 = 4.7; p < 0.05). When the 
reward was devalued through LiCl-pairing, control females had significantly higher 
Approach relative to their counterparts in the non-devalued condition (Fig. 3.2 A). 
Furthermore, when the reward was devalued, control females exhibited significantly 
higher Approach than control males and adult-exposed females. When Post-CS entries 
during the first trial only were analyzed, 3-way repeated measures ANOVA revealed a 
sex by value interaction (F1,115 = 6.0; p < 0.05). In males, Post-CS entries were 
significantly lower in the devalued compared to non-devalued condition and this 
difference was driven by control males (p = 0.051 devalued vs. non-devalued) 
demonstrating appropriate devaluation (Fig. 3.2 B). In contrast to controls, AMPH-




Rats from experiment 1b readily acquired Pavlovian conditioning across 10 days 
of training. Three-way repeated measures ANOVA of Approach revealed significant 
main effects of sex (F1,89 = 13.1; p < 0.001), day (F9,801 = 34.1; p < 0.001), and a sex by 
day interaction (F9,801 = 2.2; p < 0.05). Overall, females exhibited higher Approach than 
males and all groups exhibited higher Approach on days 2-10 compared to day 1. The 
interaction revealed that females engaged in significantly more Approach than males on 
days 2, 4, and 6-10 of conditioning (Fig. 3.4 A-B).  
As expected, when the reward was devalued (paired condition), rats in the 
second experiment reduced consumption of pellets. Four-way repeated measures 
ANOVA of pellets consumed revealed significant main effects of value (F1,85 = 528.5; p 
< 0.001) and day (F2,169 = 239.1; p < 0.001) and significant sex by day (F2,169 = 4.6; p < 
0.05) and value by day (F2,169 = 330.4; p < 0.001) interactions. Consistent with the first 
experiment, differences between devalued and non-devalued groups were only 
apparent on day 2 and during the aversion probe. Furthermore, reward devaluation 
again had a greater impact in males, as males in the devalued condition consumed 
significantly fewer pellets on day 2 than females (Fig 3.4 C-D). There was a small, but 
significant decrease in number of pellets consumed in the non-devalued group on day 1 
of reward devaluation compared to day 2 and the aversion probe.     
Prior to the devaluation test, AMPH-exposed rats were challenged with a 5-
HT2CR antagonist. Three-way ANOVA of Approach and Post-CS entries during the first 
trial in males revealed no significant main effects or interactions (Fig. 3.5 A-B). In 
contrast to the first experiment, pre-planned comparisons revealed that adult-exposed 
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males treated with vehicle exhibited appropriate devaluation (p < 0.05 devalued vs. non-
devalued; Fig 3.5 B).  
In females, 3-way ANOVA of Approach during trial 1 revealed a significant main 
effect of value (F1,38= 4.2; p < 0.05). When the reward was devalued, AMPH-exposed 
females engaged in significantly more Approach than when the reward value was left 
intact. This difference was driven by adult-exposed females pretreated with SB 242084 
who tended to engage in more Approach when the reward had been devalued, 
compared to non-devalued (p = 0.078; Fig. 3.6 A). Three-way ANOVA of Post-CS 
entries during trial 1 in females revealed a significant treatment by value by drug 
interaction (F1,38= 6.7; p < 0.01). When the reward was devalued, pretreatment with the 
5-HT2CR antagonist significantly reduced Post-CS entries of adolescent-exposed 
females compared to those treated with vehicle. This effect was consistent with the 
appropriate devaluation observed in adolescent-exposed females treated with the 5-
HT2CR antagonist (p < 0.05 devalued vs. non-devalued; Fig 3.6 B).  
Discussion 
This study sought to determine the impact of adolescent or adult AMPH exposure 
on reward devaluation and, subsequently, the impact of 5-HT2CR antagonism on 
devaluation in AMPH-exposed rats. Consistent with my hypothesis, rats exposed to 
AMPH failed to exhibit devaluation. Surprisingly, the impact of devaluation in control 
females was to increase conditioned responding to the CS. Blocking 5-HT2CRs with pre-
treatment of SB 242084 restored devaluation of goal-directed behavior in adolescent-
exposed females and tended to restore female-typical devaluation of stimulus-directed 
behavior in adult-exposed females. However, in apparent contrast to experiment 1a, 
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adult-exposed males treated with vehicle exhibited appropriate goal-directed 
devaluation. The findings from experiment 1a are consistent with the hypothesis that 
AMPH pretreatment impairs OFC-sensitive cognitive flexibility and the findings from 
experiment 1b suggest there may be a sex-specific impact of AMPH exposure on 5-
HT2CRs. However, the results of this study must be taken with caution as there were 
some internal inconsistencies between the 2 experiments. 
Rats trained in both experiments readily acquired the Pavlovian association 
between flashing lights and delivery of food pellets. Generally, females exhibited higher 
Pavlovian conditioning than males, but in the first experiment, this depended on age of 
exposure. The finding that females exhibit more conditioned responding than males is 
consistent with previous studies (Leuner et al., 2004; Dalla and Shors, 2009; 
Hammerslag and Gulley, 2013; Pitchers et al., 2015), however, this can be a subtle and 
strain-dependent effect (Pitchers et al., 2015). The lack of main effect of AMPH 
exposure on conditioned responding is inconsistent with previous reports that 
psychostimulant exposure increases Pavlovian conditioning (Harmer and Phillips, 1998; 
Taylor and Jentsch, 2001; Wyvell and Berridge, 2001), but others have reported no 
effect of AMPH pretreatment (Schoenbaum and Setlow, 2005; Wan and Peoples, 
2008). The differences with the former studies could be due to differences in stimulus 
modality (Taylor and Jentsch, 2001; Wyvell and Berridge, 2001), amount and duration 
of AMPH exposure (Harmer and Phillips, 1998; Taylor and Jentsch, 2001; Wyvell and 
Berridge, 2001), conditioning protocols (Harmer and Phillips, 1998; Taylor and Jentsch, 
2001; Wyvell and Berridge, 2001), or interval between AMPH exposure and Pavlovian 
conditioning (Harmer and Phillips, 1998; Taylor and Jentsch, 2001; Wyvell and 
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Berridge, 2001). That AMPH exposure enhanced conditioning in adolescent- compared 
to adult-exposed females in experiment 1a only was surprising, but could have been a 
result of litter effects (Zorrilla, 1997; Fitzpatrick et al., 2013). Differences in Pavlovian 
conditioning have been observed between vendors and even between colonies within a 
vendor (Fitzpatrick et al., 2013) and, although litters were counterbalanced across 
groups within experiments, they were not counterbalanced between experiments 1a and 
1b. Importantly, across 10 days of conditioning all rats developed robust conditioned 
responding to the CS.   
Pairing LiCl with the food pellet reward robustly decreased pellet consumption in 
both experiments. Consistent with previous research (Chambers et al., 1981; Sherrill et 
al., 2011; Schramm-Sapyta et al., 2014), LiCl-induced reward devaluation had a greater 
impact in males than females, as evidenced by significantly reduced pellet consumption 
on day 2 of devaluation procedures. Generally, females appear to be less sensitive to 
the impact of conditioned taste aversion, as they have also been shown to extinguish 
conditioned taste aversions more readily than males (Chambers and Sengstake, 1976; 
Sengstake et al., 1978; Randall-Thompson and Riley, 2003). Interestingly, in 
experiment 1a there was an age-of-exposure dependent effect of AMPH treatment on 
LiCl-induced devaluation in females. On day 2, adolescent-exposed females exhibited 
greater devaluation than all other females and their male counterparts. Again, that this 
effect was only observed in the first experiment is surprising and may again be the 
impact of litters only counterbalanced within experiments (Zorrilla, 1997). Importantly, all 
groups significantly reduced pellet consumption following LiCl pairing and demonstrated 
similar amounts of reward devaluation on the aversion probe.  
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The pattern of responding during devaluation testing in control females was the 
opposite of what is expected for appropriate devaluation. Specifically, when the reward 
was devalued, control females significantly increased conditioned responding to the CS 
relative to their non-devalued counterparts and to control males in the devalued 
condition. This pattern of responding is inconsistent with a study that used a within-
subjects, reward-specific devaluation paradigm (Holland, 1998). The critical difference 
between the studies is that in Holland’s study females learned 2 CS-US Pavlovian 
associations, one of which was devalued by LiCl-pairing. As such, devaluation was 
demonstrated by comparing conditioned responding for the 2 CSs within the same 
subjects. Notably, the current study is the first we are aware of to examine between-
subjects, LiCl-induced reward devaluation in females. As such, although the increase in 
conditioned responding following reward devaluation is counter to the expected 
behavior based on studies using males (Pickens et al., 2003, 2005), there is no 
evidence to suggest it is an aberrant response to this devaluation paradigm in females. 
A sex difference in devaluation was certainly expected, as our lab has demonstrated 
previously that females continue responding significantly more for a CS previously 
paired with a devalued outcome than males, when that outcome is devalued through 
satiety (Hammerslag and Gulley, 2013). However, in that study there was no non-
devalued (e.g. unpaired) condition to which female’s devalued behavior could be 
compared. Importantly, higher CS responding in females relative to males following 
devaluation (Hammerslag and Gulley, 2013) is consistent with the behavior observed in 
the current experiment.  
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Support for the argument that, within this paradigm, our control female’s behavior 
represents a generalizable sexual dimorphism in reward devaluation comes from 
studies partitioning conditioned responding into stimulus- or goal-directed (Flagel et al., 
2009). Stimulus-directed behavior is oriented towards the stimulus predictive of reward, 
while goal-directed behavior is oriented to the location where the goal is delivered. In 
the current study, stimulus- and goal-directed behavior during the CS could not be 
distinguished because CRs could only be measured where the goal was delivered, so 
the two were conflated under the current conditions. However, during devaluation 
testing, goal-directed behavior could be inferred by examining entries immediately 
following the CS (Post-CS entries) and entries during the CS could again be interpreted 
as either stimulus- or goal-directed. The significance of distinguishing between these 
types of CRs is that stimulus-, but not goal-directed behavior, is resistant to reinforcer 
devaluation (Morrison et al., 2015). In fact, stimulus-directed behavior was found to be 
enhanced following reinforcer devaluation (Morrison et al., 2015), consistent with the 
behavior in our control females. As is the case with stimulus-directed behaviors, if the 
CS acquires incentive motivational properties (Flagel et al., 2009; Robinson and Flagel, 
2009), the value of the outcome represented will have less of an influence on behavior 
elicited by the CS. This was supported recently by studies demonstrating that stimulus-, 
but not goal-directed behavior, is resistant to extinction (Beckmann and Chow, 2015; 
Ahrens et al., 2016). As such, the disparate impact of reward devaluation in our control 
males and females could be the result of an increased tendency to engage in stimulus-
directed behavior in our control females. Consistent with this hypothesis is evidence 
demonstrating that females engage in more stimulus-directed behavior than males 
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(Pitchers et al., 2015). Interestingly, assessment of Post-CS entries, which could serve 
as a proxy for goal-directed behavior, provided our most robust evidence for devaluation 
in control males. This is consistent both with our assertion that males engaged in more 
goal-directed behavior and the finding that goal-directed, but not stimulus-directed 
behavior, is sensitive to reward devaluation (Morrison et al., 2015). In the absence of 
known studies to the contrary, the evidence supports the assertion that the behavior 
observed in our control females represents the true impact of devaluation on 
conditioned responding, however, more studies are needed to confirm this conclusion. 
That AMPH-exposed rats did not exhibit reward devaluation in experiment 1a is 
consistent with deficits observed previously in males pretreated with AMPH or cocaine 
(Schoenbaum and Setlow, 2005; Hankosky and Gulley, 2012; Hankosky et al., 2013) 
and with the hypothesis that AMPH treatment impairs OFC-sensitive cognitive flexibility 
(Pickens et al., 2003, 2005; West et al., 2011). The deficits in cognitive flexibility 
observed here and in my previous studies (Hankosky and Gulley, 2012; Hankosky et 
al., 2013) are suggestive of dysregulated 5-HT (Clarke et al., 2005; Brown et al., 2012; 
West et al., 2013) and, more specifically, 5-HT2CRs in the OFC (Boulougouris et al., 
2008; Boulougouris and Robbins, 2010). The lack of age-dependent deficits in AMPH-
exposed rats is consistent with the impact of AMPH exposure on reversal learning 
(Hankosky et al., 2013) and impulsivity (Hammerslag et al., 2014) in male rats. 
However, our lab (Sherrill et al., 2013; Hammerslag et al., 2014) and others (Harvey et 
al., 2009; Counotte et al., 2011) have observed more severe deficits in PFC-sensitive 
tasks following adolescent, compared to adult, psychostimulant exposure. These 
differences could be the result of polydrug exposure (Sherrill et al., 2013), exposure to a 
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significant stressor (Hammerslag et al., 2014), assessing cognitive performance 
following equal withdrawal periods (Counotte et al., 2011), or route of drug 
administration (Harvey et al., 2009), all of which differed from the current study. Notably, 
even within the same experiment (Hammerslag et al., 2014), our lab has both detected 
and failed to detect an age-dependent deficit in impulse control in male rats. As such, 
age-dependent deficits in PFC-sensitive tasks that are assessed following different 
periods of withdrawal may be subtle and, under certain circumstances, difficult to detect. 
This may account for the lack of age-dependent deficits observed in females rats that 
our lab has previously reported for impulse control (Hammerslag et al., 2014).   
Serotonin-2C receptor antagonism appeared to age-dependently restore 
devaluation of stimulus- and goal-directed behaviors. When the reward had been 
devalued, treating adolescent-exposed females with SB 242084 prior to devaluation 
testing significantly reduced Post-CS entries (‘goal-directed’ behavior) relative to vehicle 
treated rats. Consistent with this effect, adolescent-exposed females pretreated with SB 
242084 exhibited appropriate devaluation, in that rats in the devalued condition made 
significantly fewer Post-CS entries on trial 1 than rats in the non-devalued condition. 
Interestingly, pretreatment with SB 242084 tended to make conditioned responding to 
the CS (‘stimulus-directed’ behavior) in adult-exposed females similar to that found in 
our control females. These results are consistent with my hypothesis that AMPH-
induced deficits in cognitive flexibility are mediated in part by changes in 5-HT2CRs. 
Interestingly, 5-HT2CR antagonism in adolescent-exposed females restored putative 
goal-directed behavior and in adult-exposed females tended to restore putative 
stimulus-directed behavior. This could be the result of differences in stimulus- and goal-
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directed behavior between adolescent- and adult-exposed females. Repeatedly, adults 
have been shown to exhibit more stimulus-directed behavior than adolescents 
(Anderson and Spear, 2011; Doremus-Fitzwater and Spear, 2011; Anderson et al., 
2013) and AMPH exposure enhances stimulus-directed behavior in females (Doremus-
Fitzwater and Spear, 2011). Although AMPH was shown to increase stimulus-directed 
behavior in both adolescent and adult females, the effect tended to be greater in adults 
(Doremus-Fitzwater and Spear, 2011). Furthermore, it is possible that the impact of 
AMPH on stimulus-directed behavior had dissipated in adolescent-exposed females 
(given the prolonged withdrawal) biasing their behavior towards goal-directed. This 
could account for the disassociation of how 5-HT2CR antagonism restored devaluation in 
adolescent- and adult-exposed females.  
The evidence for a restorative effect of 5-HT2CR antagonism on devaluation was 
limited to females. SB 242084 pretreatment abolished appropriate devaluation in adult-
exposed males and had no effect on adolescent-exposed males. To the first of these 
effects, unlike in the first experiment, adult-exposed males pretreated with vehicle 
exhibited appropriate devaluation (Post-CS responses: non-devalued > devalued). One 
possibility is that AMPH exposure does not impair outcome devaluation in adult-
exposed males and we failed to detect this devaluation in the first experiment. Given the 
impact of stimulus- versus goal-directed behavior on devaluation (Morrison et al., 2015) 
and the heterogeneity of the phenotype in homogenous populations (Fitzpatrick et al., 
2013), it seems plausible that random variation in the occurrence of stimulus- and goal-
directed rats masked devaluation in adult-exposed males in experiment 1a. If this is the 
case, it is similar to a study from our lab that at first failed to detect, and then in a 
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subsequent experiment detected, an age-dependent PFC-sensitive cognitive 
impairment in males (Hammerslag et al., 2014). Regarding the impact of the drug on 
devaluation, it is important to note that when the reward was devalued, there were no 
differences in responding between adult-exposed males treated with SB 242084 or 
vehicle. In fact, the significant difference between devalued and non-devalued 
conditions in adult-exposed males treated with vehicle appears to be due to elevated 
responding in the non-devalued condition. As such, when the reward was devalued the 
drug had no impact on responding in adult-exposed males.  However, if the devaluation 
in adult-exposed males treated with vehicle is not an artifact of heightened responding 
in the non-devalued group, the drug challenge data would suggest that there is an 
optimal range of 5-HT2CR function for devaluation and that the drug challenge shifted 
adult-exposed males out of the optimal range. This is consistent with the dose-
dependent effect of SB 242084 on reversal learning (Boulougouris et al., 2008),  
Although I expected 5-HT2CR antagonism to restore devaluation in all AMPH-
exposed rats, the sexual dimorphism is consistent with sex differences in lesion-induced 
cognitive deficits (Kolb and Cioe, 1996), distribution of 5-HT receptors (Biver et al., 
1996; Zhang et al., 1999), and long-term consequences of psychostimulant exposure 
(Robinson, 1984; Hammerslag et al., 2014; Shanks et al., 2014). In a battery of tasks, 
females with mPFC lesions exhibited more severe impairments than males (Kolb and 
Cioe, 1996), suggesting that insults to the PFC are more severe, or at least functionally 
different, in females compared to males. Furthermore, repeated AMPH exposure is 
known to have a sexually dimorphic impact on cognition (Hammerslag et al., 2014), 
locomotor sensitization (Robinson, 1984; Shanks et al., 2014), and neurobiological 
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outcomes (Cholanian et al., 2014). Given that the 5-HT2CR antagonist was delivered 
systemically, sex differences in regional distribution of 5-HT2CRs could account for the 
differences in devaluation upon challenge. Although sex differences in the distribution 
and expression of 5-HT2CRs have not been studied, there are known sex differences in 
5-HT2 receptor expression in humans (Biver et al., 1996) and 5-HT2A/1A receptors in rats 
(Zhang et al., 1999). As such, some combination of sex-specific differences in baseline 
and/or AMPH-induced cognitive deficits or 5-HT2CR expression could account for the 
sex-dependent impact of 5-HT2CR antagonism on outcome devaluation.   
The current study theoretically replicates my previous work (Hankosky and Gulley, 
2012; Hankosky et al., 2013) demonstrating that AMPH exposure impairs OFC-sensitive 
cognitive flexibility. This extended my previous work to include females, revealing that 
these AMPH-induced deficits in outcome devaluation may not depend on sex. 
Furthermore, systemic challenge with a 5-HT2CR antagonist restored devaluation in 
AMPH-exposed females, providing support for the hypothesis that AMPH-induced 
changes in 5-HT2CRs contribute to AMPH-induced deficits in cognitive flexibility. 
However, these conclusions should be considered with caution, because there were 
some inconsistencies between the experiments that may have resulted from a lack of 
litter balancing between the experiments (Zorrilla, 1997). Importantly, though, the impact 
of AMPH on reward devaluation in females was internally consistent between the 2 
experiments. Although the interpretation of the findings is consistent my hypothesis and 
supported by evidence from the literature, these claims can only be confirmed with 
additional testing. Therefore, the age- and sex-dependent impact of AMPH exposure on 
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Tables and Figures 
 
Table 3.1. Treatment and experimental timeline for experiment 1. Male and female 
Sprague-Dawley rats were treated with saline or AMPH during adolescence and 
adulthood. All rats received one injection, every other day, for a total of 10 injections 







Figure 3.1 Pavlovian conditioning and reward devaluation. Rats were given 10 daily 
Pavlovian conditioning sessions, during which a 10-sec flashing light stimulus predicted 
delivery of food reward. (A) Males (N = 20-22/group) and (B) Females (N = 20-
22/group) significantly increased their Approach (CS trough entries – pre-CS trough 
entries) behavior across days. Groups received 10 min access to pellets with 
(paired/devalued) or without (unpaired/non-devalued) immediate injection of LiCl. (C) 
Males (n = 10-11/pairing condition) and (D) females (n = 10-11/pairing condition) that 
had LiCl paired with pellets significantly reduced their intake across exposures. ### p < 





Figure 3.2 Devaluation test in control rats. Devaluation was tested in a single 
session, wherein the CS was presented 8 times under extinction conditions. When (A) 
Approach and (B) Post-CS entries were analyzed on the first trial of the devaluation 
test, the impact of devaluation in control rats became evident. Non-devalued = unpaired, 
devalued = paired. ** p < 0.01 non-devalued vs. devalued control females; ## p < 0.01 





Figure 3.3 Devaluation test in AMPH-exposed rats. AMPH-exposed rats did not 
exhibit devaluation when (A) Approach or (B) Post-CS entries were assessed on the 





Figure 3.4 Experiment 1b conditioning and reward devaluation. (A) Males (n = 23-
24/group) and (B) females (n = 19-27/group) significantly increased Approach behavior 
across Pavlovian conditioning days. When the pellets were subsequently paired 
(devalued) or unpaired (non-devalued) with LiCl injection (C) males (n = 11-13/pairing 
condition) and (D) females (n = 9-15/pairing condition) in the devalued conditioned 
significantly reduced consumption of pellets. ### p < 0.001 vs. day 1; *** p < 0.001 





Figure 3.5 5-HT2CR antagonist challenge in AMPH-exposed males. (A) Approach 
and (B) Post-CS entries during trial 1 in AMPH-exposed males pre-treated with vehicle 
(VEH; n = 4-8/group) or 1 mg/kg SB 242084 (SB; n = 4-8/group) 20 min prior to the 




Figure 3.6 5-HT2CR antagonist challenge in AMPH-exposed females. (A) Approach 
and (B) Post-CS entries during trial 1 in AMPH-exposed females pre-treated with 
vehicle (VEH; n = 3-8/group) or 1 mg/kg SB 242084 (SB; n = 5-7/group) 20 min prior to 
the devaluation test. * p < 0.05 non-devalued (unpaired) vs. devalued (paired); # p < 




CHAPTER 4: AGE- AND SEX-SPECIFIC DIFFERENCES IN METHAMPHETAMINE 
SEEKING 
Rationale 
Adolescent and female drug users are at heightened risk for addiction and 
differences in patterns of intake may account for their vulnerability. For example, 
although females report fewer opportunities to use drugs, they initiate use just as 
frequently as males when given the opportunity (Van Etten and Anthony, 2001). 
Furthermore, earlier onset use of stimulants increases the likelihood of transitioning 
from oral administration to snorting (Teter et al., 2006). Several studies in rodents 
support the hypothesis that, under certain conditions, adolescents (Anker and Carroll, 
2010; Anker et al., 2012; Wong et al., 2013; Wong and Marinelli, 2015) and females 
(Roth and Carroll, 2004; Shahbazi et al., 2008) engage in heightened drug seeking. 
However, few studies have investigated differences in self-administration of AMPHs 
(Roth and Carroll, 2004; Shahbazi et al., 2008; Anker et al., 2012) and only one 
examined the interaction of age and sex in the same study (Shahbazi et al., 2008). This 
is the first study we are aware of to examine age and sex differences in METH seeking. 
This experiment will also make possible assessment of cognitive and neurobiological 
consequences of volitional drug intake.  
Several studies demonstrate that contingency of drug administration (i.e. 
experimenter- vs. self-administered) plays a modulatory role in drug-induced 
neuroadaptations and behavioral outcomes (Dworkin et al., 1995; Stefanski et al., 1999; 
Robinson et al., 2002; Crombag et al., 2005; Kippin et al., 2006; Lominac et al., 2012; 
Laćan et al., 2013; Caffino et al., 2014). For example, contingency of drug 
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administration has been shown to impact the nature and direction of changes in drug-
induced neurotransmitter efflux (Lominac et al., 2012), spine density (Robinson et al., 
2002), molecular markers of learning and memory (Caffino et al., 2014), and drug 
lethality (Dworkin et al., 1995). Moreover, deficits on an OFC-sensitive task were more 
severe in adolescent rats with a history of METH self-administration than their yoked 
controls who received the drug non-contingently (Harvey et al., 2009). As such, the 
current experiment will improve our understanding of addiction vulnerability in 
adolescents and females in two ways: first by elucidating age of onset- and sex-
dependent differences in METH seeking and, second, by facilitating assessment of the 
relationship between METH seeking and cognitive and neurobiological consequences of 
contingent drug exposure. To accomplish this, I will assess acquisition of METH self-
administration at three doses (0.02, 0.05, 0.08 mg/kg/inf) and motivation for METH 
(0.02, 0.05, 0.08, 0.1 mg/kg/inf) under a PR schedule of reinforcement.  
Methods 
Male and female Sprague-Dawley rats, which were offspring of rats bred in our 
colony, were assigned to one of four groups (n = 7-17/group) based on age of onset and 
reinforcer (see Table 4.1). Rats were pair-housed on a reverse light/dark cycle (lights off 
at 0900) and all behavior was conducted during the dark cycle. The adolescent-onset 
groups were implanted with indwelling jugular vein catheters on P32 (± 2 days) and, 
following 6-8 days recovery, on P40 were habituated to the operant chambers for 90 
min, during which time access to the nosepoke ports was blocked (Wong et al., 2013). 
On P41, separate groups of rats were trained across 15 sessions to self-administer 
METH at a dose of either 0.02, 0.05, or 0.08 mg/kg/infusion (adolescent-onset METH). 
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Self-administration sessions were 120-min during which responses in a recessed hole 
(“active” nosepoke) were reinforced with an infusion of METH (40-80 µl delivered over 
2-4 sec) and responses in a second hole (“inactive” nosepoke) had no scheduled 
consequence. Separate groups of rats received non-contingent infusions of saline 
(adolescent-onset saline) approximated to match the number of infusions earned by 
their METH self-administering counterparts. For both groups, onset of a tone (2.9 kHz, 
80 dB) and cue light above the active nosepoke port coincided with infusion of METH or 
saline. For the duration of the study, rats had ad libitum access to food and water 
except for the first three days of self-administration (i.e. habituation and first 2 days on 
FR1). On these days, food was removed 2 h prior to the session and returned 30 min to 
2 h after the session to encourage spontaneous acquisition of METH self-
administration. 
The acquisition period consisted of 7 sessions of responding on a fixed ratio (FR) 
1 schedule of reinforcement followed by 4 sessions each of FR3 and FR5. Since 
acquisition was highest at the 0.08 mg/kg/inf dose, rats that acquired at that dose were 
then tested for motivation to respond for 4 doses of METH (0.02, 0.05, 0.08, 0.1 
mg/kg/infusion) during separate 5-h sessions on a PR schedule of reinforcement. For 
PR, the training dose was always tested first and the remaining doses were 
counterbalanced across sessions. Between each PR session, rats were given a 
maintenance session with the training dose of METH available on a FR5 schedule of 
reinforcement.   
Rats in the adult-onset groups were handled and weighed daily until they 
reached P82 (± 2 days), at which time they underwent identical surgical and self-
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administration procedures that rats in the adolescent-onset groups began on P32 (see 
Table 4.1). Rats were either assigned to self-administer METH (adult-onset METH) or 
receive non-contingent infusions of saline (adult-onset saline) approximated to match 
that of their sex- and age-matched counterparts. Because they had the highest levels of 
METH intake, adolescent- and adult-onset rats that acquired self-administration at the 
0.08 mg/kg/inf dose were moved on to Experiments 3 and 4 (Aim 1) to assess cognitive 
flexibility and 5-HT2CR expression in the OFC (see Table 4.1). Rats that received non-
contingent infusions of saline served as the control group for these experiments. 
Data Analysis 
Dependent measures included number of active nosepokes, inactive nosepokes, 
infusions earned, and sessions to reach acquisition criterion. Rats were considered to 
have acquired METH self-administration if their average intake was ≥ 1 mg/kg, (1) 
throughout the acquisition period, and (2) across the last 4 sessions on FR5. The 4th out 
of 5 sessions when a rat self-administered ≥ 1 mg/kg METH was designated as the 
session on which criterion was reached. Sessions to reach acquisition criterion were 
analyzed for each dose with a two-way (age x sex) ANOVA. Active nosepokes were first 
analyzed in separate two-way mixed factor ANOVAs (acquisition x session) at each 
dose to determine if the acquisition criterion split rats into groups that were behaviorally 
distinct. Subsequently, only data from rats that met acquisition criterion were included in 
analyses. Active nosepokes, inactive nosepokes, and infusions from these rats were 
collapsed across FR schedules and analyzed separately for each dose with three-way 
(age x sex x ratio) mixed factor ANOVAs. For PR tests, infusions and inactive 
nosepokes were analyzed. These were analyzed in separate three-way (age x sex x 
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dose) repeated measures ANOVAs. Significant main effects and interactions were 
followed up with Tukey’s post-hoc tests.      
Results 
Across 15 sessions of METH self-administration, rats were classified as either 
having met acquisition criterion or not having met acquisition criterion. Separate two-
way ANOVAs of sessions to acquisition criterion revealed a main effect of age at the 
lowest dose (F1,28 = 7.0; p < 0.05)  and main effect of sex at the highest dose (F1,42 = 
4.6; p < 0.05). Adult-onset rats acquired METH self-administration at the lowest dose 
significantly faster than adolescent-onset rats and females reached acquisition criterion 
at the highest training dose significantly faster than males (Fig. 4.1 A,C,E see inset). 
The latter effect was driven by the low percentage of adolescent-onset males that 
achieved acquisition criterion at the highest training dose. 
To demonstrate that rats meeting acquisition criterion behaved differently than 
rats that did not, separate two-way ANOVAs of active nosepokes across acquisition 
were analyzed. At each dose there was a significant main effect of session (0.02: F14,417 
= 11.9; p < 0.001; 0.05: F14,742 = 22.4; p < 0.001; 0.08: F14,616 = 7.7; p < 0.001), 
acquisition (0.02: F1,30 = 79.1; p < 0.001; 0.05: F1,53 = 153.7; p < 0.001; 0.08: F1,44 = 
29.0; p < 0.001), and a session by acquisition interaction (0.02: F14,417 = 11.6; p < 0.001; 
0.05: F14,742 = 15.4; p < 0.001; 0.08: F14,616 = 3.9; p < 0.001). Post-hoc analyses 
revealed that at the 0.05 and 0.08 mg/kg/inf doses, there were no differences between 
rats that met acquisition criterion and those that did not on sessions 1 through 7, and 
that group differences emerged when the response requirement was increased to FR3 
on session 8 and persisted for the remainder of acquisition (Fig. 4.1 D,F). A similar 
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pattern emerged at the lowest dose, such that acquisition groups did not differ 
significantly during FR1 responding (with the exception of sessions 3, 4, and 7), but did 
significantly differ on sessions 8 through 15 (Fig. 4.1 B).  
In the subsets of rats that acquired METH self-administration at the 0.05 and 
0.08 mg/kg/inf doses, active nosepokes, inactive nosepokes, and infusions were 
collapsed across FR schedules and analyzed in separate three-way ANOVAs. At both 
doses, there were no significant effects of inactive nosepokes, demonstrating that 
inactive nosepokes were unaffected by the FR schedule (Fig. 4.2 A,C see inset). 
However, for active nosepokes there was a significant main effect of ratio at both doses 
(0.05: F2,62 = 144.9; p < 0.001; 0.08: F2,74 = 162.8; p < 0.001). Post-hoc analyses 
demonstrated that active hole responding increased as the ratio requirement increased 
(i.e. all ratios differed significantly from all others; Fig. 4.2 A,C). Analysis of infusions 
earned revealed a main effect of ratio at the highest dose (F2,74 = 21.3; p < 0.001) and 
post-hoc analyses showed that FR1 differed significantly from FR3 and FR5 (Fig. 4.2 
D). This was driven by reduced number of infusions earned by adolescent-onset males 
with increasing ratio requirements. The lack of effect for the intermediate dose 
demonstrates that rats adjusted their nosepoke responding to maintain similar levels of 
intake at each reinforcement schedule, as did most groups at the 0.08 mg/kg/inf dose.  
Rats who were trained to self-administer METH at the highest dose were tested 
for motivation to procure the drug at four doses during 5-h PR sessions. Three-way 
repeated measures ANOVA of infusions earned revealed significant main effects of age 
(F1,37 = 6.9; p < 0.05) and dose (F3,111 = 38.6; p < 0.001). The main effect of age 
demonstrated that adult-onset rats reached significantly higher breakpoints than 
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adolescent-onset rats. Investigation of the main effect of dose revealed that rats earned 
significantly fewer infusions at the lowest dose compared to all other doses and at 0.05 
mg/kg/inf compared to 0.1 mg/kg/inf (Fig. 4.3 A). Analysis of inactive nosepokes 
revealed a main effect of dose (F3,111 = 9.6; p < 0.001) and a sex by dose interaction 
(F3,111 = 4.0; p < 0.01). Post-hoc analyses demonstrated that males made significantly 
fewer inactive nosepokes at the lowest dose than at any other dose (Fig. 4.3 B).  
Discussion 
This study sought to examine age- and sex-dependent differences in acquisition 
of METH self-administration and motivation for METH. Surprisingly, adult-onset rats 
acquired METH self-administration faster than adolescent-onset rats at the lowest dose 
and adolescent-onset males consistently had the slowest rates of acquisition. However, 
these differences in rates of acquisition did not confer higher responding for or intake of 
METH across 15 sessions of acquisition on FR schedules of reinforcement. When 
motivation for the drug was assessed on a PR schedule of reinforcement, adult-onset 
rats worked the hardest for METH at all doses tested. These results suggest that under 
certain conditions, adolescent-onset and female rats do not exhibit heightened drug-
seeking compared to their counterparts.   
Analysis of active and inactive nosepokes across acquisition demonstrated that 
rats distinguished between the two holes and oriented behavior towards the active hole 
in a manner that resulted in consistent levels of METH intake. Although rats made more 
inactive than active nosepokes, their inactive hole responding did not change as a 
function of increasing the ratio schedule as active hole responding did. This 
demonstrates that inactive responding provides an index of motor activation. The motor 
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activation explanation of inactive hole responding is supported by the profile of 
responding during PR sessions. Male rats made significantly more inactive responses at 
the three highest doses compared to the lowest dose, demonstrating a dose-dependent 
increase in motor activation consistent with METH’s locomotor-activating effects. 
Notably, inactive hole responding was higher in this study than others (Wong et al., 
2013; Wong and Marinelli, 2015), but that could be due to the proximity of the inactive to 
the active port in the current experiment. An alternative and complementary possibility is 
that having the port adjacent to a corner increased stereotypies in the inactive hole. In 
studies where inactive responding is lower than observed here (Wong et al., 2013; 
Wong and Marinelli, 2015), the inactive port is located on the wall opposite the active 
port instead of on the same wall as was the case here. 
The finding that adult-onset rats acquired METH self-administration more readily 
at lower doses and reached higher breakpoints under a PR schedule than their 
adolescent-onset counterparts was surprising, but consistent with some emerging 
literature. Schassburger et al. (2016) recently demonstrated that adult (P90 at onset) 
males and females acquire nicotine self-administration at a lower dose and self-
administer more nicotine at this dose than adolescents of both sexes (P30 at onset). 
These findings are also consistent with Anker et al. (2012), who demonstrated that 
adolescent (P26-28 at onset) and adult (P93-103 at onset) males do not differ in METH 
intake when it is available on a FR1 schedule of reinforcement for 2 h (Shahbazi et al., 
2008; Anker et al., 2012). Only when access was extended to 6 h did adolescent rats 
take more METH than their adult counterparts. The current findings are not, however, 
consistent with findings from Kyle Frantz’ lab (Shahbazi et al., 2008) demonstrating that 
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adolescent (P35-38 at onset) males and females acquire AMPH self-administration 
more readily at a lower dose and self-administer more AMPH than adults (P90-92 at 
onset). Several methodological differences could account for the disparate findings. 
Shahbazi et al. (2008) shipped the groups in at different ages (P22 and P77 for 
adolescents and adults, respectively), conducted self-administration sessions during the 
rats’ light cycle, and maintained responding on a FR1 schedule of reinforcement for the 
duration of acquisition. As such, it is possible that the shipment stress that occurred 
around weaning only in the adolescent group and/or age differences in activity during 
rats’ sleep cycle resulted in faster acquisition of AMPH self-administration. Indeed, 
studies have demonstrated that early life stress increases acquisition of METH (Lewis et 
al., 2013, 2016) and cocaine (Kosten et al., 2000; Baarendse et al., 2013) self-
administration and that age differences in ethanol consumption, which are not apparent 
when rats are tested during the dark cycle, emerge when rats are tested in the light 
cycle (Walker et al., 2008). However, other studies have reported a decrease in cocaine 
self-administration in rats (Martini and Valverde, 2012) and non-human primates 
(Corcoran and Howell, 2010) following early life stress. Importantly, the impact of peri-
weanling shipment stress cannot be disassociated from the age-dependent differences 
in AMPH self-administration observed in that study. Lastly, the current results 
demonstrate that increasing the response requirement was a critical factor in separating 
rats that met acquisition criterion from those that did not, as these groups did not differ 
in active hole responding until the response requirement was increased.  
The age-dependent differences in METH self-administration we observed 
suggest that adolescent-onset rats are less sensitive to the reinforcing effects of METH 
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compared to their adult-onset counterparts. This is consistent with some (Adriani and 
Laviola, 2003), but not all (Mathews and McCormick, 2007; Zakharova et al., 2009), of 
the literature examining age-dependent differences in the reinforcing effects of drugs 
using conditioned place preference (CPP). For example, adolescent rats have been 
shown to acquire CPP for METH more readily than adults (Zakharova et al., 2009), but 
others find no age-dependent differences (Mathews and McCormick, 2007) or reduced 
CPP for AMPH in adolescents (Adriani and Laviola, 2003). Studies examining age-
specific sensitivity to psychostimulants by assessing motor activation have been 
similarly equivocal. Some groups report that adolescent rats exhibit heightened 
sensitization to AMPHs (Mathews et al., 2011), while others report less motor activation 
in adolescents compared to adults (Mathews and McCormick, 2007; Zakharova et al., 
2009). One possibility is that pharmacokinetic differences could account for reduced 
sensitivity to AMPHs in adolescence, but findings are again mixed. Studies examining 
plasma and brain levels of stimulants have found that adolescents have lower levels 
(Spear and Brake, 1983; Kokoshka et al., 2000; McCarthy et al., 2004; Craig et al., 
2014), higher levels (Caster et al., 2005; Zombeck et al., 2009), or no difference in 
levels compared to adults (McCarthy et al., 2004; Caster et al., 2005; Zombeck et al., 
2009). As such, it is unclear if reduced sensitivity to stimulants, conferred by age-
dependent differences in pharmacokinetics, contributed to reduced METH self-
administration in our adolescent-onset rats. These hypotheses would require further 
testing.   
In the current study, the only sex difference observed was in acquisition of METH 
self-administration at the highest dose and this difference was driven by delayed 
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acquisition in adolescent-onset males. Within age groups, there were no sex differences 
in METH intake or breakpoints reached during PR testing. These findings are consistent 
with some (Shahbazi et al., 2008; Reichel et al., 2012), but not all of the existing 
literature (Roth and Carroll, 2004). In adult rats, Shahbazi et al. (2008) observed no sex 
differences in PR responding for AMPH, but found that males self-administered more 
AMPH than females. Reichel et al. (2012) found that males and females self-administer 
similar amounts of METH when it is available on a FR1 schedule of reinforcement for 1 
h and that sex differences only emerge when the drug is available for 6 h. Similarly, 
Roth and Carroll (2004) demonstrated that when rats are individually housed and drug 
is available 6 h per day, females acquire METH (0.02 mg/kg/inf) self-administration 
more readily than males and reach higher breakpoints under a PR schedule of 
reinforcement. This sex difference in motivation for METH could be a result of the single 
housing conditions. Westenbroek et al. (2013) demonstrated that single housed females 
reach significantly higher breakpoints for cocaine than their pair-housed counterparts 
and males from both housing conditions. Importantly, there were no differences in PR 
responding between pair-housed males and females.  
Together, these results do not support the hypothesis that heightened drug 
seeking and motivation contribute to poorer outcomes of drug use in the vulnerable 
populations studied here. At first glance, these findings are not consistent with the 
epidemiological evidence demonstrating that adolescents and females (Becker and Hu, 
2008; Dluzen and Liu, 2008; Gonzales et al., 2008) have more severe progressions and 
outcomes of addiction. However, several factors may contribute to the apparent 
disparity. The human drug taking experience is far more complex than modeled in this 
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study. Human drug users often are polydrug users (von Mayrhauser et al., 2002; 
Simonsen et al., 2015), present with co-mordid psychiatric disorders (Denier et al., 
1991; Ridley and Coleman, 2015), and have complex motivations for engaging in drug 
use (von Mayrhauser et al., 2002; Mccabe et al., 2005). As such, under the current 
conditions there was little evidence for heightened drug seeking in adolescents or 
females. However, a large body of evidence (Roth and Carroll, 2004; Shahbazi et al., 
2008; Reichel et al., 2012; Wong et al., 2013) indicates that under certain conditions 
adolescents and females do exhibit heightened drug seeking. In conjunction with 
epidemiological findings (Becker and Hu, 2008; Dluzen and Liu, 2008; Gonzales et al., 
2008), the preponderance of evidence suggests that factors specific to the adolescent 
and female drug taking experience coalesce to result in poorer long-term outcomes of 
drug use. For example, early onset drug use may prime individuals for heightened or 
different patterns of later drug use. In humans, individuals who initiated stimulant use 
before college were more likely than those who initiated during college to snort 
stimulants (versus oral intake) and cite experimentation and getting high as motivations 
for drug use (Teter et al., 2006). Furthermore, female drug users are more likely than 
males to present with co-morbid disorders (Denier et al., 1991) and report different 
motivations to use stimulants than males (Teter et al., 2006). As such, it seems likely 
that factors surrounding drug use in adolescents and females contribute to their drug 
use outcomes. Lastly, although the current findings did not provide evidence to help 
explain poorer drug use outcomes in females and adolescents, the study resulted in rats 
that administered high levels of METH. These rats were subsequently used to test the 
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hypothesis that cognitive and neurobiological consequences of drug exposure 




Adriani W, Laviola G (2003) Elevated levels of impulsivity and reduced place 
conditioning with d-amphetamine: Two behavioral features of adolescence in mice. 
Behav Neurosci 117:695–703. 
Anker JJ, Baron TR, Zlebnik NE, Carroll ME (2012) Escalation of methamphetamine 
self-administration in adolescent and adult rats. Drug Alcohol Depend 124:149–
153. 
Anker JJ, Carroll ME (2010) Reinstatement of cocaine seeking induced by drugs, cues, 
and stress in adolescent and adult rats. Psychopharmacology 208:211–222. 
Baarendse PJJ, Limpens JHW, Vanderschuren LJMJ (2013) Disrupted social 
development enhances the motivation for cocaine in rats. Psychopharmacology 
231:1695–1704. 
Becker JB, Hu M (2008) Sex differences in drug abuse. Front Neuroendocrinol 29:36–
47. 
Caffino L, Cassina C, Giannotti G, Orrù A, Moro F, Di Clemente A, Racagni G, 
Fumagalli F, Cervo L (2014) Short-term abstinence from cocaine self-
administration, but not passive cocaine infusion, elevates αCaMKII 
autophosphorylation in the rat nucleus accumbens and medial prefrontal cortex. Int 
J Neuropsychopharmacol 17:323–329. 
Caster JM, Walker QD, Kuhn CM (2005) Enhanced behavioral response to repeated-
dose cocaine in adolescent rats. Psychopharmacology 183:218–225. 
Corcoran SBE, Howell LL (2010) Impact of early life stress on the reinforcing and 




Craig EL, Zhao B, Cui JZ, Novalen M, Miksys S, Tyndale RF (2014) Nicotine 
Pharmacokinetics in Rats is altered as a function of Age, impacting the 
Interpretation of Animal Model Data. Drug Metab Dispos 42:1447–1455. 
Crombag HS, Gorny G, Li Y, Kolb B, Robinson TE (2005) Opposite effects of 
amphetamine self-administration experience on dendritic spines in the medial and 
orbital prefrontal cortex. Cereb cortex 15:341–348. 
Denier CA, Thevos AK, Latham PK, Randall CL (1991) Psychosocial and 
psychopathology differences in hospitalized male and female cocaine abusers: A 
retrospective chart review. Addict Behav 16:489–496. 
Dluzen DE, Liu B (2008) Gender Differences in Methamphetamine Use and 
Responses : A Review. Gend Med 5:24–35. 
Dworkin SI, Mirkis S, Smith JE (1995) Response-dependent versus response-
independent presentation of cocaine: differences in the lethal effects of the drug. 
Psychopharmacology 117:262–266. 
Gonzales R, Ang A, McCann MJ, Rawson RA (2008) An Emerging Problem: 
Methamphetamine Abuse Among Treatment Seeking Youth. Subst Abus 29:71–80. 
Harvey RC, Dembro KA, Rajagopalan K, Mutebi MM, Kantak KM (2009) Effects of self-
administered cocaine in adolescent and adult male rats on orbitofrontal cortex-
related neurocognitive functioning. Psychopharmacology 206:61–71. 
Kippin TE, Fuchs RA, See RE (2006) Contributions of prolonged contingent and 
noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in 
rats. Psychopharmacology 187:60–67. 
101 
 
Kokoshka JM, Fleckenstein AE, Wilkins DG, Hanson GR (2000) Age-dependent 
differential responses of monoaminergic systems to high doses of 
methamphetamine. J Neurochem 75:2095–2102. 
Kosten TA, Miserendino MJD, Kehoe P (2000) Enhanced acquisition of cocaine self-
administration in adult rats with neonatal isolation stress experience. Brain Res 
875:44–50. 
Laćan G, Hadamitzky M, Kuczenski R, Melega WP (2013) Alterations in the striatal 
dopamine system during intravenous methamphetamine exposure: Effects of 
contingent and noncontingent administration. Synapse 67:476–488. 
Lewis CR, Staudinger K, Scheck L, Olive FF (2013) The effects of maternal separation 
on adult methamphetamine self-administration, extinction, reinstatement, and 
MeCP2 immunoreactivity in the nucleus accumbens. Front Psychiatry 4:1–9. 
Lewis CR, Staudinger K, Tomek SE, Hernandez R, Manning T, Olive MF (2016) Early 
life stress and chronic variable stress in adulthood interact to influence 
methamphetamine self-administration in male rats. Behav Pharmacol 27:182–184. 
Lominac KD, Sacramento AD, Szumlinski KK, Kippin TE (2012) Distinct neurochemical 
adaptations within the nucleus accumbens produced by a history of self-
administered vs non-contingently administered intravenous methamphetamine. 
Neuropsychopharmacology 37:707–722. 
Martini M, Valverde O (2012) A single episode of maternal deprivation impairs the 
motivation for cocaine in adolescent mice. Psychopharmacology 219:149–158. 
Mathews IZ, Kelly H, McCormick CM (2011) Low doses of amphetamine lead to 
immediate and lasting locomotor sensitization in adolescent, not adult, male rats. 
102 
 
Pharmacol Biochem Behav 97:640–646. 
Mathews IZ, McCormick CM (2007) Female and male rats in late adolescence differ 
from adults in amphetamine-induced locomotor activity, but not in conditioned place 
preference for amphetamine. Behav Pharmacol 18:641–650. 
Mccabe SE, Knight JR, Teter CJ, Wechsler H (2005) Non-medical use of prescription 
stimulants among US college students : prevalence and correlates from a national 
survey. Addiction 99: 96–106. 
McCarthy LE, Mannelli P, Niculescu M, Gingrich K, Unterwald EM, Ehrlich ME (2004) 
The distribution of cocaine in mice differs by age and strain. Neurotoxicol Teratol 
26:839–848. 
Reichel CM, Chan CH, Ghee SM, See RE (2012) Sex differences in escalation of 
methamphetamine self-administration: cognitive and motivational consequences in 
rats. Psychopharmacology 223:371–380. 
Ridley K, Coleman M (2015) The epidemiology of amphetamine type stimulant-related 
admissions in Albany, Western Australia: 2008–2013. Australas Psychiatry 23:241–
244. 
Robinson TE, Gorny G, Savage VR, Kolb B (2002) Widespread but regionally specific 
effects of experimenter- versus self-administered morphine on dendritic spines in 
the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 
46:271–279. 
Roth ME, Carroll ME (2004) Sex differences in the acquisition of IV methamphetamine 
self-administration and subsequent maintenance under a progressive ratio 
schedule in rats. Psychopharmacology 172:443–449. 
103 
 
Schassburger RL, Pitzer EM, Smith TT, Rupprecht LE, Thiels E, Donny EC, Sved AF 
(2016) Adolescent rats self-administer less nicotine than adults at low doses. 
Nicotine Tob Res: epub ahead of print. 
Shahbazi M, Moffett AM, Williams BF, Frantz KJ (2008) Age- and sex-dependent 
amphetamine self-administration in rats. Psychopharmacology 196:71–81. 
Simonsen KW, Edvardsen HME, Thelander G, Ojanperä I, Thordardottir S, Andersen L 
V., Kriikku P, Vindenes V, Christoffersen D, Delaveris GJM, Frost J (2015) Fatal 
poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int 248:172–
180. 
Spear LP, Brake SC (1983) Periadolescence: Age-Dependent Behavior and 
Psychopharmacological Responsivity in Rats. Dev Psychobiol 16:83–109. 
Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR (1999) Neuroadaptations in 
the dopaminergic system after active self-administration but not after passive 
administration of methamphetamine. Eur J Pharmacol 371:123–135. 
Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ (2006) Illicit Use of Specific 
Prescription Stimulants Among College Students: Prevalence, Motives, and Routes 
of Administration. Natl Inst Heal 26:1501–1510. 
Van Etten ML, Anthony JC (2001) Male-female differences in transitions from first drug 
opportunity to first use: searching for subgroup variation by age, race, region, and 
urban status. J Womens Health Gend Based Med 10:797–804. 
von Mayrhauser C, Brecht M-L, Anglin D (2002) Use ecology and drug use motivations 
of methamphetamine users admitted to substance abuse treatment facilities in Los 
Angeles. J Addict Dis 21:45–60. 
104 
 
Walker BM, Walker JL, Ehlers CL (2008) Dissociable effects of ethanol consumption 
during the light and dark phase in adolescent and adult Wistar rats. Alcohol 42:83–
89. 
Westenbroek C, Perry AN, Becker JB (2013) Pair housing differentially affects 
motivation to self-administer cocaine in male and female rats. Behav Brain Res 
252:68–71. 
Wong WC, Ford KA, Pagels NE, McCutcheon JE, Marinelli M (2013) Adolescents are 
more vulnerable to cocaine addiction: behavioral and electrophysiological evidence. 
J Neurosci 33:4913–4922. 
Wong WC, Marinelli M (2015) Adolescent-onset of cocaine use is associated with 
heightened stress-induced reinstatement of cocaine seeking. Addict Biol 21:634–
645. 
Zakharova E, Leoni G, Kichko I, Izenwasser S (2009) Differential effects of 
methamphetamine and cocaine on conditioned place preference and locomotor 
activity in adult and adolescent male rats. Behav Brain Res 198:45–50. 
Zombeck JA, Gupta T, Rhodes JS (2009) Evaluation of a pharmacokinetic hypothesis 
for reduced locomotor stimulation from methamphetamine and cocaine in 




Tables and Figures 
 
 
Table 4.1 Timeline of procedures for experiments 2-4. Adolescent- and adult-onset 
rats were trained to self-administer METH at 0.02, 0.05, or 0.08 mg/kg/inf across 15 
sessions. Subsequently, rats that acquired at the highest dose were tested for 
motivation to procure METH at four doses during PR sessions. Following PR testing, 
these rats then completed a cognitive flexibility task and their brains were removed for 




Figure 4.1. Acquisition of METH self-administration at three doses. Rats were 
trained to self-administer METH at 0.02 mg/kg/inf (top panel), 0.05 mg/kg/inf (middle 
panel), and 0.08 mg/kg/inf (bottom panel). The left side of each panel shows (A,C,E) 
percent of rats reaching acquisition criterion, (A,C,E inset) sessions to criterion, and 
(B,D,F) active nosepokes across acquisition. Sample size indicated on the bars in the 
inset graph. * p < 0.05 adult- vs. adolescent-onset; # p < 0.05 males vs. females; ** p < 




Figure 4.2. Nosepokes and infusions earned collapsed across ratio. For rats who 
reached acquisition criterion at 0.05 mg/kg/inf (top panel) and 0.08 mg/kg/inf (bottom 
panel) data were collapsed across ratio. The left side of each panel shows (A,C) active 
nosepokes and (A,C inset) inactive nosepokes (collapsed across groups). The right 






Figure 4.3. Dose-response motivation for METH. (A) Infusions and (B) inactive 
nosepokes during PR sessions tested at four doses following acquisition at 0.08 
mg/kg/inf. * p < 0.05 adult-onset vs. adolescent-onset; # p < 0.05 0.05 mg/kg/inf vs. 0.1 
mg/kg/inf; ** p < 0.01 vs. lowest dose within males; *** p < 0.001 lowest dose vs. all 
other doses.  
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CHAPTER 5: AGE- AND SEX-SPECIFIC EFFECTS OF METHAMPHETAMINE SELF-
ADMINISTRATION ON COGNITIVE FLEXIBILITY AND SEROTONIN-2C 
RECEPTORS IN THE ORBITOFRONTAL CORTEX 
Rationale 
Drug-induced neuroadaptations and cognitive dysfunction represent possible 
mechanisms through which the cycle of drug-dependence (periods of abstinence 
disrupted by relapse) is perpetuated (Rogers and Robbins, 2001). Previously, I have 
demonstrated that rats exhibit long-lasting deficits on OFC-sensitive tasks following 
experimenter-administered AMPH (Hankosky and Gulley, 2012; Hankosky et al., 2013). 
To extend those findings and investigate a candidate mechanism responsible for these 
deficits, rats from experiment 2 were tested for cognitive flexibility in an operant strategy 
shifting task and, subsequently, co-expression of 5-HT2CRs with PV-ir interneurons was 
assessed. Because we did not detect AMPH-induced deficits in a prior operant strategy 
shifting task (Hankosky et al., 2013), two important changes were made to the current 
protocol. First, rats were overtrained on the response that would eventually be reversed 
and, second, the response reversal occurred within a single session. Overtraining can 
increase the difficulty of reversal learning (Hill et al., 1962; Hicks, 1964) and generally 
biases behavior towards being perseverative and inflexible (Faure et al., 2010; Lingawi 
and Balleine, 2012). Moreover, within-session reversals are more challenging than 
between-session reversals (MacKintosh et al., 1968) and thereby increase the likelihood 
of detecting age-dependent differences (Watson et al., 2006). 
Based on the deficits I observed following repeated AMPH exposure (Hankosky 
and Gulley, 2012; Hankosky et al., 2013), I hypothesize that rats with a history of METH 
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self-administration will be impaired on a task of cognitive flexibility and that these 
deficits will be accompanied by upregulation of 5-HT2CRs on PV-ir neurons in the OFC. 
The AMPH-induced deficits in cognitive flexibility I have observed are known to depend 
on 5-HT2CRs in the OFC (Boulougouris and Robbins, 2010). In the PFC, 5-HT2CRs are 
primarily localized to PV-ir interneurons (Liu et al., 2007), which provide tight regulatory 
control of pyramidal cell output (Markram et al., 2004). PFC modulation of subcortical 
structures is critical for cognition (Graybeal et al., 2012) and an upregulation of 5-
HT2CRs on PV-ir neurons might disrupt GABAergic modulation of pyramidal projection 
neurons. As such, an increase in the co-expression of 5-HT2CRs with PV-ir interneurons 
could be a mechanism responsible for the OFC-sensitive deficits I observed in AMPH-
treated rats (Hankosky and Gulley, 2012; Hankosky et al., 2013). This experiment will 
test the hypothesis that METH self-administration results in cognitive inflexibility that is 




Male (n = 6-10/group) and female (n = 10-15/group) rats from experiment 2 (Ch. 
4) that received saline or met acquisition criterion at the highest dose of METH (0.08 
mg/kg/inf) were used for experiment 3. Rats were pair-housed on a reverse light/dark 
cycle (lights off at 0900) and all behavior was assessed during the dark cycle. On P67 
or 118 (adolescent- or adult-onset; see Table 4.1) rats began training on an operant 
strategy shifting task (Hankosky et al., 2013). During all behavioral training and testing, 
rats were fed ad libitum 20-22 h/day. Two hours prior to each daily session, food was 
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removed and then returned 30 to 120 mins following task. Rats were trained and tested 
in standard operant chambers (Coulbourn Instruments; Whitehall, PA, USA) that were 
housed inside sound-attenuating cubicles. The chambers were identical to those 
described previously by our lab (Hankosky et al., 2013).  
Operant procedures began with one session of magazine training, during which 
38 pellets were delivered to the food trough on a variable interval 100-sec schedule. 
Subsequently, rats were trained during four 30-min sessions (1 session/day) to respond 
on one of two levers on a FR1 schedule of reinforcement. During these sessions, only 
one lever was extended into the chamber and the available lever was alternated each 
day. Following lever press training, rats were trained during five sessions to respond 
within 10-sec of lever extension into the chamber. Each rat’s side bias was then 
established in a single session as described by Floresco et al. (2008).  
 Strategy shifting sessions, which were given once per day, consisted of 120 trials 
that were separated by a 10-sec intertrial interval. Trials began when both levers were 
inserted into the chamber concurrent with illumination of one of the two cue lights 
located above the levers. Trials were ended after either the rat pressed the lever or 10-
sec elapsed. Individual cue lights were presented pseudorandomly across trials, such 
that no cue light could be presented on more than two consecutive trials. Because all 
rats had prior exposure to cue lights in experiment 2, during visual strategy sessions the 
cue light illuminated 2-sec prior to trial onset to increase its saliency (Floresco et al., 
2008).  
Rats were first trained to use a visual strategy by reinforcing them (with delivery 
of a food pellet) for pressing the lever that had a cue light illuminated above it, 
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regardless of the lever’s spatial location (i.e., left or right side of pellet delivery trough). 
Trials continued until rats achieved ten consecutive correct choices and had completed 
at least 30 trials. On the day following acquisition of this performance criterion, rats were 
required to shift to an egocentric response strategy. This required that rats press a lever 
relative to its position, regardless of cue light location (e.g. always press the left lever). 
The location of the reinforced lever for the response strategy was determined 
individually for each rat such that it was the lever opposite of the rat’s side bias that was 
observed during initial training (see above). Trials continued until rats achieved a 
criterion of eight consecutive correct choices.  
Following acquisition of the response strategy, rats were overtrained during a 
single session consisting of 150 trials reinforcing the previously acquired response 
strategy. Following overtaining, rats completed a within-session reversal. During this 
session, rats were first required to demonstrate retention of the overtrained response by 
pressing that lever eight consecutive times. Once retention of the overtrained response 
was confirmed, the stimulus-reward association was reversed such that pressing on the 
previously non-rewarded lever now resulted in reinforcement (e.g. always press the 
right lever). As before, trials continued until rats achieved a criterion of eight consecutive 
correct choices. For all stages of the task, trials where rats failed to respond on a lever 
within 10-sec of trial onset were terminated, scored as an omission, and led to the 
intertrial interval.  
Data Analysis 
Cumulative METH intake from experiment 2 was analyzed in a two-way ANOVA 
(age x sex). Dependent measures used to assess cognitive flexibility included the 
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number of trials and errors to criterion. Errors following the shift to the response strategy 
were classified as perseverative or never-reinforced. Perseverative errors were defined 
as those that would have been correct when the visual strategy was in effect (e.g., 
responding in the left port when the left cue light was illuminated, but the right port 
response was the reinforced response). All other errors were scored as never-
reinforced, as they would not have been correct in a visual strategy and they included 
responses in the non-reinforced port during the response strategy. Because drug-
induced deficits are sometimes evident early, but not later in training (Kondrad and 
Burk, 2004; Hankosky and Gulley, 2012; Hankosky et al., 2013), errors during the first 
30 trials of the shift to response and response reversal were analyzed. Rats that did not 
acquire the visual strategy (METH/SAL: n = 3/3 adolescent-onset male, n = 7/3 
adolescent-onset female, n = 3/4 adult-onset male, n = 4/3 adult-onset female) were not 
included in the shift from visual to response analysis (Hankosky et al., 2013), resulting 
in the following sample sizes: males: n = 3-6/group; females: n = 6-9/group. To be 
included in the response reversal, rats were required to complete ≥ 100 overtraining 
trials (SAL: n = 1 adolescent-onset male excluded), resulting in the following sample 
sizes: males: n = 6-10/group; females: n = 10-15/group. Trials and errors for each 
strategy were analyzed in three-way ANOVAs (treatment x sex x age-of-onset). Error 
types were analyzed separately in males and females using three-way repeated 
measures ANOVA (treatment x age x type). Pre-planned comparisons were used to 






A subset of rats (n = 6/group) that completed experiments 2 and 3, were matched 
for cumulative METH intake (37.7 ± 5.4 mg/kg) and assigned to experiment 4. Rats 
were chosen for this analysis based on METH intake, such that groups did not differ 
significantly. The amount of METH intake was set by the adolescent-onset males 
because that group had the smallest sample size from which to choose rats. Control 
rats were littermates of METH rats when possible. Seven to ten days following 
completion of operant strategy shifting (at P96 ± 4 or P147 ± 3; ~5 weeks after last 
METH exposure), rats were deeply anesthetized (100 mg/kg pentobarbital) and 
transcardially perfused with phosphate buffered saline (PBS; 10 mmol/L; pH 7.2) and 
3% paraformaldehyde in PBS. Following removal, brains were post-fixed for at least 2 h 
at room temperature in 3% paraformaldehyde in PBS and then immersed in a 
cryoprotectant (30% sucrose) at 4 °C until the brains sunk. Subsequently, 40-µm thick 
sections including the OFC were taken with a freezing microtome and stored in 
cryoproctectant at -20 °C until processed.  
Free-floating coronal sections (40 µm) containing the OFC (between +3.2 and 
+4.2 from bregma) were stained with 5-HT2CR antibody and the calcium-binding protein 
antibody, PV, as described previously (Liu et al. 2007). Specifically, the anti-5HT2C 
polyclonal antibody raised in goat (1:100 dilution; sc-15081, Santa Cruz Biotechnology) 
and the anti-PV monoclonal antibody raised in mouse (1:2500 dilution; PV 235, 
SWANT) were used with fluorescent secondary antibodies Alexa Fluor® 488 (anti-goat, 
1:500 dilution; A-11055 Invitrogen Corporation)) and Alexa Fluor® 555 (anti-mouse, 
1:2000 dilution; A-31570, Invitrogen Corporation)  to visualize 5-HT2CR expression and 
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colocalization to PV-ir interneurons (Bubar et al., 2005; Liu et al., 2007). To rule out 
cross-reactivity, control sections were stained with the secondary antibodies in the 
presence of only one primary antibody. Images were collected at 20X magnification with 
a fluorescent confocal microscope (Zeiss LSM 880) and captured and processed with 
the Zen software package. Sixty PV-ir cells from layer V of the OFC of each rat were 
counted from 1-2 sections (bregma +3.70 mm). The number of those cells that also co-
expressed the 5-HT2CR was then counted and the percentage of PV-ir interneurons that 
co-expressed 5-HT2CRs was calculated.  
Data Analysis 
The dependent measure was percent of PV-ir interneurons that co-expressed 5-
HT2CRs (number of PV-ir cells co-expressing 5-HT2CRs divided by the number of PV-ir 
neurons counted * 100). Sixty PV-ir interneurons were counted for each rat. Percent 
colocalization was analyzed with a four-way repeated measures ANOVA (treatment x 
sex x age-of-onset x hemisphere). The percent of 5-HT2CRs colocalized to PV-ir 
interneurons was correlated using linear regression with METH intake and errors 
committed early (first 30 trials) in reversal learning. For some rats, all PV-ir interneurons 
were counted from the same hemisphere (males: n =1 adult-onset METH; n = 3 adult-
onset saline; females: n = 1 adolescent-onset METH; n = 1 adult-onset saline).  
Results 
Rats from experiment 2 administered high levels of METH over 22 self-
administration sessions. Two-way ANOVA of these data revealed no significant main 
effects or interaction, demonstrating that groups did not differ in cumulative METH 
intake (Fig. 5.1 A). Following self-administration, rats were tested in an operant strategy 
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shifting task. Acquisition of the initial, visual strategy was assessed by examining trials 
and errors to criterion and percent correct choices. Three-way ANOVA of trials, errors, 
and percent correct choices revealed no significant main effects or interactions. 
However, pre-planned comparisons revealed that adolescent-onset females with a 
history of METH self-administration required significantly more trials (t46 = 2.2; p < 0.05) 
and committed significantly more errors (t46 = 2.1; p < 0.05) than their sex- and age-
matched controls (Fig. 5.1 B,C).  
Cognitive flexibility was then assessed with a shift from visual to response 
strategy. Three-way ANOVA of trials (Fig. 5.2 A), errors, and percent correct choices 
revealed no significant main effects or interactions. Errors that occurred during the shift 
were characterized as either perseverative or never reinforced. For males and females, 
three-way repeated measures ANOVAs revealed no significant main effects or 
interactions (data not shown). There were also no significant main effects or interactions 
when performance during the first 30 trials (early) was assessed (Fig. 5.2 B).   
The second assessment of cognitive flexibility was tested when the overtrained 
response strategy was reversed. As part of the within-session reversal, rats were first 
required to make 8 consecutive correct choices of the overtrained response. 
Interestingly, three-way ANOVAs revealed a significant main effect of age for both 
errors committed (F1,73 = 4.4; p < 0.05) and percent correct (F1,73 = 9.5; p < 0.01) during 
retention of the overtrained response. Adult-onset rats, regardless of sex or treatment, 
committed significantly more errors and made significantly fewer percent correct 




Once rats completed 8 consecutive correct choices of the overtrained response, 
the response strategy was reversed. Three-way ANOVA of trials (Fig. 5.4 A), errors, 
and percent correct revealed no significant main effects or interactions. However, when 
performance during the first 30 trials (early) was examined, three-way ANOVA revealed 
a significant treatment by sex by age-of-onset interaction (F1,73 = 7.4; p < 0.01). Early in 
training, adolescent-onset females committed significantly more errors than their 
controls and adult-onset females (Fig. 5.4 B). In contrast, adult-onset females 
committed significantly fewer errors than their controls.  
A subset of brains from rats that completed the strategy shifting experiment were 
stained for 5-HT2CRs and the PV calcium binding protein (Fig. 5.5). Four-way repeated 
measures ANOVA revealed a significant treatment by sex by age-of-onset by 
hemisphere interaction (F1,34 = 4.2; p < 0.05). In the left hemisphere, adult-onset males 
had significantly higher colocalization of 5-HT2CRs with PV-ir interneurons than their 
controls and adolescent-onset males (Fig. 5.6 A). Percent colocalization was not 
significantly correlated with METH intake or reversal errors committed early in training 
(data not shown).     
Discussion 
This study examined the impact of METH self-administration on cognitive 
flexibility and co-expression of 5-HT2CRs with PV-ir interneurons in the OFC. Although 
the experimental groups administered similar amounts of METH, only adolescent-onset 
females were significantly impaired during acquisition of the visual strategy and early in 
the reversal. Interestingly, in spite of not exhibiting deficits in the reversal task, adult-
onset males had significantly upregulated 5-HT2CRs colocalized to PV-ir interneurons in 
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the left hemisphere of the OFC. These results support a role for age- and sex-specific 
effects of METH exposure in cognitive dysfunction, identify a potential mechanism for 
deficits observed previously in adult-exposed males, and reveal targets for future 
studies on the neurobiological impact of METH exposure.   
Assessment of cognitive flexibility in rats with a history of METH self-
administration revealed age- and sex-dependent deficits in initial discrimination learning 
and reversal learning early in training. Discrimination learning depends on intact 
corticostriatal circuits (Winocur and Eskes, 1998; Fidalgo et al., 2014) and reversal 
learning relies on the OFC (McAlonan and Brown, 2003; Boulougouris et al., 2007), 
suggesting that METH self-administration in adolescent-onset females disrupts 
corticostriatal and OFC-sensitive functions. That the reversal deficit was only observed 
early in training is consistent with other studies showing transient AMPH-induced 
deficits in PFC-sensitive tasks (Kondrad and Burk, 2004; Hankosky and Gulley, 2012; 
Hankosky et al., 2013). Even in studies where a brain region is lesioned, cognitive 
deficits have been shown to dissipate with training (Mar et al., 2011; Ostrander et al., 
2011). The reversal deficit is consistent with my hypothesis that METH self-
administration impairs OFC-sensitive cognitive flexibility and the discrimination learning 
deficit is conceptually consistent with my hypothesis of prefrontal-corticostriatal circuit 
impairments in adolescent-exposed females. The age-dependency of the deficits is 
consistent with evidence demonstrating that exposure to psychostimulants during 
adolescence, compared to adulthood, results in greater cognitive impairments (Harvey 
et al., 2009; Counotte et al., 2011; Sherrill et al., 2013; Hammerslag et al., 2014). 
However, other studies (Hankosky et al., 2013; Hammerslag et al., 2014) have failed to 
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observe age-dependent deficits of psychostimulant exposure in male rats. The ability to 
detect an age-dependent effect of METH self-administration in this study, but not in 
others, may be the result of testing rats after the same withdrawal period. In the current 
study, cognitive flexibility was assessed in all groups ~2.5 weeks after the final day of 
METH self-administration, whereas in studies where an age-dependent deficit was not 
found (Hankosky et al., 2013; Hammerslag et al., 2014), adolescent-exposed rats were 
tested following a significantly longer withdrawal period than adult-exposed rats (~11 vs. 
~3 weeks, respectively). Given work showing that drug-induced changes dissipate 
following longer periods of withdrawal (Santucci et al., 2004), assessing adult- and 
adolescent-onset rats after the same period of withdrawal may have increased the 
likelihood of observing age-dependent differences in cognitive flexibility. Other 
differences between the studies are the route of drug administration and sex of the rats 
where an age-dependent deficit was observed. In some cases, OFC-sensitive cognitive 
deficits are observed following active, but not passive psychostimulant administration 
(Harvey et al., 2009) and age-dependent deficits have been observed in female, but not 
male rats (Hammerslag et al., 2014). However, in the latter study, adult-exposed 
females were more impaired on an impulse control task than adolescent-exposed 
females. This dichotomy could again be the result of route of drug administration 
(Robinson et al., 2002), extended withdrawal in adolescent-exposed females (Santucci 
et al., 2004), or type of cognitive ability being tested (Featherstone et al., 2008). In the 
same study, Featherstone et al. (2008) demonstrated that AMPH exposure impaired 
attentional set-shifting, but not working memory, suggesting that under certain 
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conditions AMPH-induced deficits may be apparent in some, but not all, tests of PFC 
function. 
 Age of exposure-dependent deficits are consistent with extended development 
during adolescence of corticolimbic brain regions responsible for executive functioning 
(Huttenlocher and Dabholkar, 1997; Giedd et al., 1999; Casey et al., 2000; Markham et 
al., 2007; Rubinow and Juraska, 2009; Willing and Juraska, 2015). The development of 
these regions is a mechanism through which experiences, such as exposure to 
psychostimulants, could result in differential neuroadaptations and cognitive deficits 
(Gulley and Juraska, 2013). Notably, when sex differences have been assessed, 
females oftentimes exhibit distinct patterns of reorganization between adolescence and 
adulthood than males (Giedd et al., 1999; Markham et al., 2007; Willing and Juraska, 
2015). Recently, Willing & Juraska (2015) demonstrated that neuronal pruning in the 
mPFC of females coincides with the onset of puberty (between P35 and P45), and as 
such, argue that this may be a sensitive window of time for PFC development in 
females. In the current experiment, adolescent-onset rats began self-administering 
METH right in the middle of this sensitive time period (P40), which could account for 
why the deficit was only observed in adolescent-onset females.  
Interestingly, adult-onset rats, regardless of sex or treatment, committed more 
errors and had significantly lower percent correct choices than adolescent-onset rats 
during retention of the overtrained response. As the response had been well-learned by 
that time in training, and there were no differences in performance during overtraining, 
the difference in retention likely reflects age-specific strategies or tendencies for 
sampling alternative options. In females, this increased sampling could explain the 
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significantly better performance early during reversal of adult- versus adolescent-onset 
rats. Although most developmental changes are thought to be complete by the time our 
adolescent-onset rats were tested (~P75), Kathleen Kantak’s lab recently observed 
differences in acquisition of a visual discrimination between rats tested at P87 and P127 
(Kantak et al., 2014). Notably, most studies of development do not examine rats 
between the ages of P60 and P90, and thus changes occurring during this time may 
have gone undetected thus far.  
Assessment of errors committed early during the response reversal revealed 
enhanced performance in adult-exposed females that self-administered METH. 
Interestingly, this is consistent with two studies that reported facilitation of operant 
strategy reversal in males exposed to AMPH during adolescence (Hankosky et al., 
2013) and in males that self-administered cocaine during adulthood (Kantak et al., 
2014). This facilitation could reflect METH-induced changes in the prelimbic mPFC. 
Stan Floresco’s lab recently demonstrated that pharmacological inactivation of the 
prelimbic mPFC enhanced probabilistic reversal learning performance by increasing 
win-stay behavior (Dalton et al., 2016). Furthermore, other studies have demonstrated a 
nuanced role for the OFC in reversal learning (Mar et al., 2011; Riceberg and Shapiro, 
2012). Mar et al. (2011) demonstrated regional specificity of the effect of OFC lesions 
on reversal learning. Specifically, lesions to the lateral OFC impaired reversal learning, 
while lesions of the medial OFC facilitated reversal learning. In another study, when the 
reward contingency was switched frequently, thereby making lose-shift tendencies 
advantageous, OFC lesions improved reversal learning (Riceberg and Shapiro, 2012). 
However, when the reward contingency was stable, like in the current study, OFC 
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lesioned animals showed the classic impairment in reversal learning (Riceberg and 
Shapiro, 2012). These studies suggest that nuanced METH-induced changes in the 
PFC or biasing behavior towards win-stay and lose-shift could account for the superior 
performance displayed by adult-onset females.  
Consistent with my previous study (Hankosky et al., 2013), males exhibited no 
deficits in acquisition of the initial discrimination. However, based on my previous work 
(Hankosky and Gulley, 2012; Hankosky et al., 2013), I expected males to display 
METH-induced deficits on OFC-sensitive cognitive flexibility. However, there was no 
evidence of cognitive deficits in either adolescent- or adult-onset males self-
administering METH. A couple of methodological differences from my previous work 
(Hankosky et al., 2013) might account for the absence of an OFC-sensitive reversal 
learning deficit here. In the previous study, the drug was experimenter-administered 
(Robinson et al., 2002; Harvey et al., 2009), the timing of exposure was different, and 
cognitive flexibility was assessed using the intradimensional/extradimensional (ID/ED) 
attentional set-shifting task. The latter is likely the best candidate to explain the 
differences observed between the studies, as the ID/ED task has distinct qualities that 
may confer different challenges. The ID/ED shifts were completed in a single day, and 
as such, there were more rule changes in close temporal proximity to the ID/ED 
reversal. Our lab has previously shown that AMPH-induced deficits on a delayed match 
to position task are largely due to proactive interference (Sherrill et al., 2013). 
Therefore, having learned and switched more rules on the same day as the ID/ED 
reversal may have increased proactive interference and made detection of an AMPH-
induced reversal learning deficit possible. In fact, the current results are consistent with 
123 
 
our previous study wherein we observed an AMPH-induced reversal deficit on the 
ID/ED task but not on a similar version of the strategy shifting task used here (Hankosky 
et al., 2013). Because there were no reversal deficits in the previous study with the 
operant strategy shifting task, two important changes were made to increase the 
likelihood of observing an AMPH-induced deficit. In the current study, rats were 
overtrained on the response strategy and a within-session reversal was used. However, 
in males we were still unable to detect reversal learning deficits with this task. This may 
suggest that the ability to detect AMPH-induced deficits depends not only on the task 
(Featherstone et al., 2008), but also task difficulty (Kantak et al., 2014).  
In the current experiment, rats that self-administered METH exhibited no deficits 
in the mPFC-mediated shift from visual to response strategy (Floresco et al., 2008). 
This was consistent with my previous work demonstrating that males exposed to AMPH 
during adolescence or adulthood did not exhibit deficits shifting from a visual to 
response strategy (Hankosky et al., 2013). However, this is in contrast to other studies 
that have observed mPFC-sensitive deficits following AMPH exposure (Featherstone et 
al., 2008; Sherrill et al., 2013; Hammerslag et al., 2014). Importantly, the current results 
do not necessarily indicate that mPFC-sensitive cognitive functions are spared following 
METH self-administration, but rather that we did not detect these differences using the 
current task.  
Assessment of 5-HT2CR colocalization with PV-ir interneurons revealed that in 
the left hemisphere, adult-onset males that self-administered METH had significantly 
higher colocalization than their age-matched controls and adolescent-onset males. The 
significant impact of hemisphere was not anticipated, but is consistent with a large body 
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of literature demonstrating laterality of monoamine levels (Staiti et al., 2011), receptor 
distribution (Schneider et al., 1982; Drew et al., 1986; Glick et al., 1988), innervation 
(Neddens et al., 2004), and function (Andersen and Teicher, 1999; Neddens et al., 
2004; Sullivan et al., 2009). Studies have found that serotonergic innervation of the PFC 
is denser in the right compared to left hemisphere (Neddens et al., 2004), dopamine 
receptors in the striatum are lateralized (Schneider et al., 1982; Drew et al., 1986; Glick 
et al., 1988), dopamine and its metabolite DOPAC exhibit lateralization in corticolimbic 
regions (Rodriguez et al., 1994), and adult rats have higher basal levels of 
norepinephrine in the right hemisphere of the ventromedial PFC than the left, while the 
opposite is true for adolescent rats (Staiti et al., 2011). Furthermore, functional 
dissociations between the hemispheres have been reported as well. Intra-nucleus 
accumbens stimulation of dopamine receptors produces greater behavioral activation 
when drug is applied to the right compared to left hemisphere (Belcheva et al., 1990) 
and rats with 5-HT lateralized to the right hemisphere of the PFC and nucleus 
accumbens exhibit more anxiety-like behavior (Andersen and Teicher, 1999). Lastly, 
chronic clomipramine (potent 5-HT reuptake inhibitor) treatment (P8-P21) reversed the 
laterality of 5-HT observed in the nucleus accumbens of control rats (left > right in 
clomipramine treated rats), but not in the PFC (Andersen et al., 2002). As such, 
lateralization of the monoamine system has a complex interplay with age, sex, and 
response to monoaminergic drugs that may account for why increased colocalization of 




Increased co-expression of 5-HT2CRs with PV-ir interneurons in adult-exposed 
males with a history of METH self-administration is consistent with my hypothesis and 
previous studies demonstrating psychostimulant-induced changes in 5-HT2CRs (Filip et 
al., 2004; Napier and Istre, 2008; Graves and Napier, 2012) and PFC GABAergic 
interneurons (Mohila and Onn, 2005; Morshedi and Meredith, 2007; Cass et al., 2013; 
Kang et al., 2016). Specifically, I hypothesized that METH exposure would result in an 
upregulation of 5-HT2CRs on PV-ir interneurons in the OFC, which may contribute to 
cognitive deficits by altering pyramidal cell output to subcortical structures. The AMPH-
induced deficits in cognitive flexibility I have observed (Hankosky and Gulley, 2012; 
Hankosky et al., 2013) are known to depend on 5-HT2CRs in the OFC (Boulougouris 
and Robbins, 2010). In the PFC, 5-HT2CRs are primarily located on PV-ir interneurons 
that have tight regulatory control over layer V pyramidal output cells (Markram et al., 
2004; Liu et al., 2007). Given the important role of PFC glutamatergic modulation of 
subcortical structures on cognition (Graybeal et al., 2012), disrupting the balance of 
inhibitory regulation of pyramidal projection neurons could disrupt cognitive functioning. 
Although these changes were observed in the absence of cognitive deficits, it is 
possible that with a more challenging task METH-induced deficits would have been 
detectable (Hankosky et al., 2013; Kantak et al., 2014). However, due to the lack of 
cognitive impairment in the group where receptor changes were observed, the 
possibility remains that the redistribution of 5-HT2CRs is unrelated to cognitive deficits. 
That METH-induced upregulation of 5-HT2CRs on PV-ir interneurons was only observed 
in adult-onset males could be the result of age- and sex-dependent differences in 
baseline or drug-induced changes to the structure and/or function of serotonergic (Biver 
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et al., 1996; Zhang et al., 1999; Moll et al., 2000; Klink et al., 2002) or GABAergic 
systems (Cruz et al., 2003; Tseng and O’Donnell, 2007; Cholanian et al., 2014; 
Gonzalez-Burgos et al., 2015). A second possibility concerns the alternative mechanism 
by which 5-HT2CR dysregulation may disrupt PFC glutamatergic output. Specifically, 
increased constitutive activity of 5-HT2CRs localized to PV-ir interneurons could diminish 
OFC glutamatergic output. Indeed, there is evidence to suggest that chronic exposure 
to elevated levels of 5-HT, like would occur with repeated psychostimulant exposure, 
increases constitutive activity of 5-HT2CRs (Devlin et al., 2004). As such, distinct 
mechanisms of 5-HT2CR-mediated OFC dysregulation, alone or in combination with 
changes to other systems, could constitute alternatives to receptor upregulation that 
disrupt cognitive flexibility, but this possibility requires further testing. A third possibility 
is that this hypothesis is tailored to adult males since it was generated with data 
obtained almost exclusively from adult males. Specifically, a majority of the evidence 
implicating the OFC (Birrell and Brown, 2000; McAlonan and Brown, 2003; 
Boulougouris et al., 2007) and 5-HT2CRs (Boulougouris et al., 2008; Boulougouris and 
Robbins, 2010) in cognitive flexibility was done in adult male rats. As such, perhaps the 
effect was only found in that group of rats because the evidence supporting the 
hypothesis was most applicable to that subgroup. 
Together, these results support the hypothesis that age- and sex-specific effects 
of METH exposure may contribute to poorer outcomes in adolescent females. METH-
induced deficits were detectable in adolescent-onset females using a task that is 
arguably less challenging (Kantak et al., 2014) than tasks where we have observed 
AMPH-induced deficits in male rats (Hankosky et al., 2013). In fact, with this simpler 
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task we failed to detect METH-induced deficits in any group other than adolescent-onset 
females. This suggests that adolescent females may be more susceptible to the 
deleterious effects of METH exposure on cognition. As such, heightened METH-induced 
cognitive deficits in females could account, in part, for their poorer trajectories of drug 
use and dependence (Moeller et al., 2001; McKellar et al., 2006; Feil et al., 2010). 
Although we did not detect METH-induced upregulation of 5-HT2CR colocalization with 
PV-ir interneurons in adolescent-onset females, the cognitive deficits in this group are 
likely accompanied by drug-induced neuroadaptations. It is even possible that 5-HT2CRs 
in the OFC are altered, but that the changes are not confined to PV-ir interneurons. The 
immunohistochemical results supported the hypothesis that METH causes upregulation 
of 5-HT2CRs on PV-ir interneurons in the OFC, but this was only observed in adult-onset 
males and in the absence of a detectable drug-induced cognitive deficit. METH-induced 
deficits may have more been detectable had the task been more challenging, 
suggesting that there may be a threshold of detection such that tasks must be 
sufficiently difficult in order to observe drug-induced deficits. Ultimately, these results 
reveal a potential mechanism through which heightened vulnerability in adolescent 
females may be conferred and suggest that changes in OFC 5-HT2CRs and inhibitory 
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Figure 5.1 METH intake and acquisition of the visual strategy. (A) Rats from 
experiment 2 had high levels of METH intake (mg/kg) that did not differ across groups. 
(B) Trials and (C) errors to reach acquisition criterion in males (n=6-10/group) and 
females (n=10-15/group) with a history of METH or saline self-administration. * p < 0.05 





Figure 5.2 Shift to response strategy. (A) Trials to criterion during the shift from visual 
to response strategy and (B) errors committed early: during the first 30 trials of the shift. 
Only data from rats that acquired the visual strategy (males: n = 3-6/group; females: n = 






Figure 5.3 Overtrained response retention. (A) Errors committed (B) and percent 
correct (correct responses divided by total responses * 100) during retention of the 
overtrained response strategy just prior to the reversal. Only data from rats that 
completed ≥ 100 overtraining trials (males: n = 6-10/group; females: n = 10-15/group) 
were included in the reversal analysis. * p < 0.05 main effect of age; ** p < 0.01 main 





Figure 5.4 Overtrained response reversal. (A) Trials to criterion for reversal of the 
response strategy and (B) errors committed early: during the first 30 trials of the 
reversal. Only data from rats that completed ≥ 100 overtraining trials (males: n = 6-
10/group; females: n = 10-15/group) were included in the reversal analysis. * p < 0.05 







Figure 5.5 5-HT2CR colocalization with Parvalbumin interneurons. Brains from a 
subset of rats from experiment 3 were stained for (A) 5-HT2CRs (green) and (B) PV 
(red) in the OFC. Subsequently, (C) Colocalization of the proteins was assessed. 





Figure 5.6 Percent 5-HT2CR colocalized with Parvalbumin interneurons. Percent 5-
HT2CR colocalization with PV-ir interneurons in the OFC of (A) males (n = 3-





CHAPTER 6: GENERAL DISCUSSION 
The studies in this Dissertation sought to examine factors that may contribute to 
heightened vulnerability in adolescents and females, based on epidemiological findings 
that drug use outcomes are poorer in these populations. My examination of drug-
induced cognitive deficits, neuroadaptations, and differences in drug-seeking using 
rodent models revealed complex relationships between age and sex. Age-dependent 
effects of drug exposure were most evident in females, perhaps in part due to the 
critical role puberty plays in the cognitive and neurobiological development of females 
(Juraska and Willing, 2016). In our model, differences in drug-seeking did not appear to 
explain differential vulnerability to addiction observed in clinical populations. However, 
consideration of multiple lines of evidence suggests that age- and sex-dependent 
differences in drug-seeking likely contribute to heightened vulnerability in adolescents 
and females. In combination with the existing literature, the studies here support the 
assertion that poorer drug use outcomes in adolescents and females are the result of 
the synergistic impact of differences in behavior, cognition, and neurobiology at baseline 
and following drug exposure. 
Working within the framework that drug-induced changes in brain and behavior 
and patterns of drug-seeking may be indicative of heightened vulnerability, many of the 
current findings do not fit with the hypothesis that adolescents and females are more 
vulnerable to the impact of AMPHs (Fig. 6.1). For example, in many of the studies there 
were no age- or sex-dependent differences, such as: the impact of AMPH on reward 
devaluation, similar levels of METH intake during self-administration across all groups, 
and similar acquisition of and motivation for METH in males and females. In some 
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instances, adolescents or females exhibited what may be considered resilience, for 
example: blunted acquisition of and motivation for METH in adolescent-onset rats 
compared to adult-onset rats and 5-HT2CR reorganization observed only in adult-onset 
males. In fact, only one finding was consistent with the original hypothesis: females that 
initiated METH self-administration during adolescence were the only group impaired on 
discrimination and reversal learning. These findings add to a growing literature that 
reveals a surprising complexity regarding factors contributing to heightened vulnerability 
in adolescents and females. Figure 6.1 illustrates the distribution of findings along a 
continuum of vulnerability and, in combination with the existing literature, it does appear 
that the scales are tipped in favor of heightened vulnerability in adolescents and 
females.  
As such, although drug-induced deficits are sometimes observed only early in 
training (Kondrad and Burk, 2004; Hankosky and Gulley, 2012; Hankosky et al., 2013; 
Sherrill et al., 2013) or not at all (Featherstone et al., 2008), and in some cases drug-
exposed rats outperform their controls (Hankosky et al., 2013; Kantak et al., 2014), the 
literature in aggregate suggests that drug exposure dysregulates the balance of normal 
behavior. These changes are likely subserved by wide-ranging drug-induced 
neuroadaptations that affect multiple neurotransmitter systems (Stefanski et al., 1999; 
Self, 2004; McCutcheon et al., 2009; Wong et al., 2013; Swinford-Jackson et al., 2016) 
across multiple corticolimbic regions (Cruz et al., 2008, 2010; Singer et al., 2009; 
Graves et al., 2015; Kang et al., 2016; Paul et al., 2016). Subtle deficits over a range of 
tasks including attention, working memory, and cognitive flexibility may have an additive 
deleterious impact on overall functioning. As such, the sometimes subtle drug-induced 
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variations in brain and behavior likely have a substantial impact on overall functioning. 
This is consistent with findings that human drug users often have difficulty with day-to-
day activities (Henry et al., 2010) yet perform within a normal cognitive range (Hart et 
al., 2012). Nonetheless, these small perturbations are accompanied by substantial 
consequences, such as relapse or failure to complete treatment (Moeller et al., 2001; 
McKellar et al., 2006; Feil et al., 2010). The chronic cognitive disadvantages and 
ubiquitous neuroadaptations, that are expressed more or differentially in adolescents 
and females, likely result in poorer outcomes. As such, it is not a single outcome of drug 
exposure, but rather the culmination of many age- and sex-specific outcomes, that 
confer heightened vulnerability in adolescents and females. Lastly, although not 
observed in our model, epidemiological data suggest that differences in drug seeking 
also contribute to heightened vulnerability in these populations, as discussed in chapter 
2.   
Future directions 
Future studies on the age- and sex-dependent effects of exposure to AMPHs 
should more directly target OFC 5-HT2CRs. For example, intra-OFC antagonism of 5-
HT2CRs during a cognitive flexibility task would delineate the specific role of those 
receptors in the OFC on cognition. Furthermore, manipulating the hemispheres 
individually could help characterize the nature and extent of AMPH-induced 
lateralization of 5-HT2CRs. Lastly, exposure to AMPHs may have changed 5-HT2CRs in 
the OFC on a global level, so future studies should examine stereological counts of 
neurons expressing HT2CRs in all cortical layers to determine if there’s a general 
upregulation of the receptors.   
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Future studies on age- and sex-dependent differences in drug-seeking should 
examine long-access conditions and higher doses of METH. Age- and sex-differences 
in drug-seeking typically emerge under long-access conditions (Anker et al., 2012; 
Reichel et al., 2012), in which rats have access to the drug for 6 h a day and tend to 
escalate intake over time (Ahmed, 2012). To my knowledge, there are no published 
studies examining the combination of age and sex differences in self-administration 
under long-access conditions. In addition to long-access conditions, future studies 
should examine acquisition of higher doses of METH. In experiment 2, there was a 
dose-dependent increase in acquisition and adolescents appeared to be on the 
ascending limb of the curve. As such, examining acquisition at higher doses may help 
fully characterize the impact of dose on acquisition in adolescents and adults.  
One aspect relevant to the examination of sex-differences that was not assessed 
in the current studies was the impact of gonadal hormones, in particular the estrous 
cycle. Several studies reveal a modulatory role of gonadal hormones on adolescent 
brain development (Juraska and Markham, 2004; Yates and Juraska, 2008; Koss et al., 
2015), the effects of drug exposure (Becker et al., 1982, 2001; Chen et al., 2003), and 
drug-seeking (Roberts et al., 1989; Lynch et al., 2001; Kantak et al., 2007; Lynch, 2009; 
Zlebnik et al., 2014). However, other studies have found no impact of estrous cycle on 
these and other outcomes  (Feltenstein et al., 2012; Reichel et al., 2012; Cox et al., 
2013; Orsini et al., 2015; Pitchers et al., 2015). Some argue that tracking 
estrous/menstrual cycle will help account for variability in female groups (Wald and Wu, 
2010; Morales and Spear, 2013), but many researchers have noted less variability in 
females than in males across a number of outcomes (Biver et al., 1996; Hammerslag 
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and Gulley, 2013; Hammerslag et al., 2014; Prendergast et al., 2014). Examination of 
sex differences as relates to the impact of drugs is a burgeoning field, so one of the 
goals of the current work was to assess sex differences using intact, freely cycling 
females (Becker and Koob, 2016). Furthermore, there was no attempt to track cycling in 
the females used in the current studies because many of the manipulations used, such 
as drug exposure (King et al., 1990, 1993; Raap et al., 2000) and food restriction (Terry 
et al., 2005; Schubert et al., 2008; Dos Santos et al., 2011), are known to disrupt 
cycling. Moreover, vaginal lavage can even alter behavioral responding to 
psychostimulants (Walker et al., 2002). As such, the impact of estrous cycling on the 
outcomes measured remains a topic for future study.  
A final consideration 
In closing, I will consider the limitations and suitability of the rodent model for 
addressing questions faced by the addiction research community. Rats have been a 
useful model for human neuropsychiatric conditions owing to their rapid lifespan, high 
reproductive rates, and homology with humans of corticolimbic circuitry and its 
development (Uylings et al., 2003). However, issues of generalizability become 
apparent when experimental outcomes are sensitive to factors such as litter, vendor, 
shipment stress, food restriction, number of cagemates, or light/dark cycle (Zorrilla, 
1997; Fitzpatrick et al., 2013; Smith et al., 2014). In light of this reality, the question 
becomes whether or not rats are a good model for such complex behaviors as drug 
seeking and executive functioning. I would argue that given certain caveats, rats are an 
excellent model in which to study drugs of abuse. In addition to the reasons mentioned 
previously, rats are a suitable alternative for the study of factors relevant to drug 
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addiction because of the precise control of experimental variables afforded by rodent 
models that is not possible in clinical populations (e.g. age of onset and cumulative 
dose). Importantly, though, it is necessary to acknowledge the limitations of the model. 
Specifically, these studies are not typically designed to address multiple complex issues 
frequently experienced by human drug users such as comorbid psychiatric disorders, 
family history, peer influence, social pressures, or job/care-giving responsibilities. 
Fortunately, studies are beginning to address some of these issues (Chen et al., 2012; 
Jordan et al., 2014; Lacy et al., 2014; Smith and Pitts, 2014; Smith et al., 2014; 
Strickland and Smith, 2015; Babinska et al., 2016), suggesting that with time and 
through systematic manipulation, the field will come to a greater understanding of 
factors contributing to addiction through the use of rodent models. The challenge will be 
to maintain a balance between modeling complexity and keeping studies simple enough 
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Figure 6.1 Preclinical evidence plotted on a continuum of vulnerability. Findings 
from the preclinical literature are plotted on a continuum of vulnerability. The far left 
includes findings where adolescents and females exhibited greater drug-induced 
deficits/neuroadaptations or engaged in heightened patterns of drug-seeking, findings 
for which there were no age- or sex-dependent differences are in the middle column, 
and those where adolescents or females had fewer deficits/neuroadaptations or 
engaged in less drug seeking are on the far right. Findings from the current dissertation 
are highlighted in purple.  
 
